NYSDEC OHMS Document No. 201469232-00113

EXHIBIT 10 NYSDEC OHMS Document No. 201469232-00113

VINCENT AGNELLO

Department of Accounting Office Tel: (716) 286 8172 College of Business Administration Fax: (716) 286 8296 Niagara University, NY 14109 Email: [email protected]

EDUCATION

Juris Doctor, University at Buffalo Law School-State University of New York, Buffalo, NY, May 1978

Bachelor of Arts, Economics, State University of New York at Buffalo, Buffalo, NY, May 1975

WORK EXPERIENCE

Professor of Law June 2003 - Present College of Business Administration, Niagara University Niagara University, NY • Designed MGT 560 course on Law and Ethics. • Taught undergraduate courses in law and introduction to business.

Visiting Professor April 2008 East China University of Science and Technology Shanghai, China • Taught two Executive MBA courses - Lega I Environment of Business

Visiting Professor Spring Semester 200 I Group ESSEC- ESSEC MBA Cergy-Pontoise, France • Designed and taught new course for ESSEC MBA on Employment Law. • Taught course on U.S. Business Law • Networked with members of the judiciary and law school faculty on research opportunities.

Associate Professor of Law June 1985 - June 2003 College of Business Administration, Niagara University Niagara University, NY

Assistant Professor of Law August 1979 - June 1985 College of Business Administration, Niagara University Niagara University, NY

Private Practice of Law June 1980-January 1998 • General and Appellate Practice • Niagara Falls & Cheektowaga Office NYSDEC OHMS Document No. 201469232-00113

LEADERSHIP EXPERIENCE

Director, Niagara University Family Business Center Fall 2003 - Present P.O. Box 1817 Niagara University. NY • Developed a Center devoted to resolving issues faced by family owned businesses. • Secured over $162,000 for the Center's operations. • Organized International Conference on Family Business for October 25-27, 2007. • Coordinated seminar series and consulting services to family owned businesses on issues involving succession planning, estate planning, taxation, and facilitating family comm uni cations. • Hosted monthly breakfast seminars using recognized experts in the area of Family Business.

Interim Dean, College of Business Administration July 200 I- July 2002 Niagara University Niagara University, NY • Guided faculty through strategic plan for the College of Business. • Hosted a suecessful business awards dinner honoring Danny Wegman, President of Wegmans Farm Markets, John Howard, CEO of Vineland Estates, and William Swan, President of First Niagara Bank. • Raised profile of the College by collaborating with over thirty entities and businesses on a grant proposal. • Successfully secured hiring of two professors in the Department of Commerce.

President, Residents for Responsible Government, Inc. March 2004 - March 2007 Youngstown. NY • Professional advisor to the Board (March 2008 - Present) • Board of Directors (July 2003 - March 2007) • Chair, Government Relations Committee (July 2003 - March 2007) • Under my leadership this grass roots organization grew from a membership of twenty residents to an organization of over 1,000 members. • Successfully forced the NYS Department of Environmental Conservation (DEC) to hold an additional public hearings in the Town of Porter. • Developed an alliance of citizens, Towns, Villages, School Districts, and elected officials. • Succeeded in getting the DEC to withdraw its proposed New York State Hazardous Waste State-wide Siting Plan . • Promoted enactment of state legislation to stop siting of hazardous waste landfills in the Great Lakes Basin. Legislation passed the Senate and Assembly and vetoed by Gov. Pataki in 2006. Same legislation passed Senate and Assembly and vetoed by Gov. Spitzer.

Board of Directors, Artpark & Company, Inc. October 2004 - Present Lewiston, NY • Secretary (October 2005 - Present) • Treasurer (October 2006 - 2008) • Chair, Finance Committee (October 2006 - 2008) • Chair, Operation Committee (October 2006 - 2008) • Chair, Strategic Planning Committee (Oct. 2004 - 2006 & 2008- 2013) NYSDEC OHMS Document No. 201469232-00113

Executive Secretary, Niagara Watershed Alliance May 2008- Present Youngstown, NY Webmaster May 2008- May 2012

Board of Directors, Aid & Care, Inc. September 2008- Present

Board of Directors, DeSales Resources and Ministry, Inc. September 201 I -Present Treasurer (September 2012-Present)

COURSES

ACC 682 CPA Research (Law only) LAW 101 Business Law I BUS 120 Introduction to Business LAW 102 Business Law II BUS 205 Legal Environment of Business LAW 301 Business Law I ECO 101 Macroeconomic Principles LAW 302 Business Law IT ECO 102 Microeconomic Principles MGT 560 Law and Ethics ECO 100 Introduction to Economics MBA 563 American Business Policy FIN 151 Personal Finance MGT314 Issues in Management HRM 301 Labor Law WRT JOO Introduction to Writing HRM 321 Employment Law

PROFESSIONAL MEMBERSHIJ>S AND HONORS

Beta Alpha Psi - BET A ALPHA PSI is an honorary organization for Financial Information students and professionals. The primary objective of Beta Alpha Psi is to encourage and give recognition to scholastic and professional excellence in the business information field. This includes promoting the study and practice of accounting, finance and information systems; providing opportunities for self-development, service and association among members and practicing professionals, and encouraging a sense of ethical, social, and public responsibility.

Beta Gamma Sigma - Beta Gamma Sigma is the honor society serving business programs accredited by AACSB International - The Association to Advance Collegiate Schools of Business. Membership in Beta Gamma Sigma is the highest recognition a business student anywhere in the world can receive in a business program accredited by AACSB International. The Mission of the International Honor Society Beta Gamma Sigma is to encourage and honor academic achievement in the study of business, to foster personal and professional excellence, to advance the values of the Society, and to serve its lifelong members. Omicron Delta Epsilon - Omicron Delta Epsilon is one of the world's largest academic honor societies. The objectives of Omicron Delta Epsilon are recognition of scholastic attainment and the honoring of outstanding achievements in economics; the establishment of closer ties between students and faculty in economics within colleges and universities, and among colleges and universities; the publication of its official journal, The Amercian Economist, and sponsoring of panels at professional meetings as well as the Irving Fisher and Frank W. Taussig competitions. Academy of Legal Studies in Business - Founded in I 924. the Academy of Legal Studies in Busine.ss (International) is an tlssociation of teachers and scholars in the fields of business law, legal environment and law-related ct)urses outside of professional law schools. NYSDEC OHMS Document No. 201469232-00113

Honors Received:

Niagara University College of Business Excellence in Teaching Award May 2014

Vincentian Mission Award September 20 I 0

Niagara University College of Business Excellence in Teaching Award May 1996

Community Service Award - from Governor State of New York June 1992

Niagara Falls Neighborhood Housing Services Community Service Award November 1989

State University of New York at Buffalo Alumni Association, Niagara Chapter- Outstanding Achievements in Practice of Law October 1983

INTELLECTUAL AND PROFESSIONAL WORK ACTIVJTIES

Journal Publications: (Refereed double blind peer review)

Agnello, Vincent, Audrey Agnello "The Sarbanes-Oxley Act Section 806: Ten Years Later.'' Journal ofBusiness , VolumeJ, Number I (2013)

Han, Lei, Vincent Agnello "Companies' Incentives to Early Adopt Statement of Financial Accounting Standards No. 142." Journal ofBw 1i11ess, Volume 3, Number I (2013) Agnello, Vincent, Audrey Agnello, Bohdan Pikas, Anastasia Pikas. "Today's Learner, Preferences in Teaching Techniques." American .Journal o.f Business Education (Volume 4, Number 2) (201 1)

Agnello, Vincent. William R. Angus, Jagat P. Anna L. McNab. " If the Customer Is Always Right, Maybe It ls Time to Listen: What Students Desire in Student and Faculty Codes of Conduct." Journal ofAdvances in Education Vol. I, Number 2 (20 10)

Cardon, Teresa, Vincent Agnello. "You Can't Always Get What You Want: Exposing Emerging Entrepreneurs to Law." Journal o,fAdvances in Educalion Vol. 1, Number 2 (2010)

Agnello, Vincent, Audrey Agnello, Bohdan Pikas. Anastasia Pikas, William R. Angus, Jagat P. Jain, Kris Principe. "Teaching Techniques That Work: The Student's Perspective." Journal of Advances in Educalion Vol. I, Number I (2010): 1-18. ISSN 2152-8810.

Agnello, Vincent. "Commentary: Vioxx and Public Policy - Taking the Right Steps." Organizational Elhics Vol. 3, Number 2 (2007): 96- 10 I. ISSN 154 1-1 036

Libby, Barbara, Vincent Agnello, and Audrey Agnello. ·'Do Ethics Courses Help Business Students Make Ethical Decisions?" The Business Review. Cambridge Volume 4, Number 2 (2005): 206-210. ISSN 1553-5827

Libby, Barbara and Vincent Agnello. "Ethical Decision Making and the Law." Journal of Business Ethics Vol. 26 (2000):223-232. ISSN 0167-4544

Gawel, Michael, Vincent Agnello. Jagat Jain. "Officers and Directors Liability Insurance," American .Journal o.f CLU, November ( 1984) NYSDEC OHMS Document No. 201469232-00113

Articles Presented and Referred Proceedings: Agnello, Vincent, Nicole F. Stolowy, Audrey Agnello, Barbara Libby. "Ethical decision Making and the Law, Some French and U.S. Examples" Presentation and Proceedings at 2013 Business research Consortium of Western New York, Canisius College, April 20 l 3.

Agnello, Vincent, Audrey Agnello "The Sarbanes-Oxley Act Section 806: Ten Years Later" Presentation and Proceedings at 2012 Business Research Consortium of Western New York, SUNY Oswego, April 2012.

Han, Lei, Vincent Agnello "Companies' Incentives to Early Adopt Statement of Financial Accounting Standards No. l 42" Presentation and Proceedings at 2012 Business Research Consortium of Western New York, SUNY Oswego, April 20 I 2.

Agnello, Vincent, William R. Angus, Jagat P. Jain, Anna McNab. "What Should be Included in Student and Faculty Codes of Conduct? Insights from University Business Students." Presentation and Proceedings at Business Research Conference, SUNY Geneseo, April 2010.

Cardon, Teresa, Vincent Agnello. "You Can't Always Get What You Want: Exposing Emerging Entrepreneurs to Law." Proceedings and presentation at Business Research Conference, SUNY Geneseo, Apri I 20 l 0.

Agnello, Vinc,ent, Nicole Stolowy. ''The Influence of U.S. Ethics in French Employment Termination: an example of"Legal Transplant'' Presentation and Proceedings of Sixteenth Annual International Conference Promoting Business Ethics, Niagara University. Niagara Falls, New York, October 2009.

Agnello, Vincent, Audrey Agnello, Bohdan Pikas, Anastasia Pikas, William R. Angus, Jagat P. Jain, Kris Principe. "Teaching Techniques That Work: The Student's Perspective." Presentation and Proceedings of the 2009 Business Research Consortium of Western New York. ISSN 2152- 8810. Rochester, New York. April 2009.

Agnello, Vincent, Nicole Stolowy. "Ethics in Labor Law: U.S. and French Comparison" Presentation and Proceedings at 15th Annual International Conference Promoting Business Ethics. De.Paul University. New York, New York. November 2008.

Agnello, Vincent, Shih-Jen Ho, and Audrey Agnello. "The Sarbanes-Oxley Act Section 806: Use of Whistle Blowing to Promote Transparency and Accountability." Presentation and Proceedings at Issues in Global Business & International Ac.counting in the 21 si Century Conference Proceedings, Universidad de Guanajuato. Guanajuato, Mexico, July 2007.

Agnello, Audrey, Vincent Agnello, and Shih-Jen Ho. "Public Accounting Perceptions of Online Accounting Courses" Presentation and Proceedings at Issues in Global Business & International Accounting in the 21 51 Century Conference Proceedings, Universidad de Guanajuato. Guanajuato, Mexico, July 2007.

Agnello, Vincent, William Angus, and Barbara Libby. " Use of Genetics Testing in Employment and Insurance - Are We Creating a New Poor Class?" Presentation and Proceedings at Thirteenth Annual International Conference Promoting Business Ethics, Niagara University. Niagara Falls. New York, October 2006. NYSDEC OHMS Document No. 201469232-00113

Libby, Barbara and Vincent Agnello, Audrey Agnello "Ethical Decision making and the Law, Some French and US Examples" Presentation and Proceedings at 6' 11 Global Conference on Business & Economics, Harvard University. Cambridge, Massachusetts, October 2006. ISBN: 0- 9742114-6

Agnello, Vincent and Shih-Jen Ho. "The Efficacy of the Whistle Blowing Provisions under Sarbanes-Oxley. Will the Framework Promote Whistle Blowing?" Presentation and Proceedings at Emerging Issues in International Accounting and Business Conference Proceedings, University of Padua. Padua, Italy, July 2006.

Libby, Barbara, Vincent Agnello, and Audrey Agnello. "Do Ethics Courses Help Business Students Make Eth ical Decisions?" Presentation and Proceedings at Economics & International Business Research Conference Proceedings. Miami, Florida, December 2005.

Libby, Barbara, Vincent Agnello, and Audrey Agnello. "Can We Teach Business Ethics?" Twelfth Annual International Conference Promoting Business Ethics, Presentation and Proceedings at SL John 's University. New York, New York, October 2005.

Libby, Barbara, Vincent Agnello, and Audrey Agnello. "Ethical Dilemmas and the Law, an International Comparison - Analysis of Decisions." Presentation and proceedings at National Business and Economics Society Sixth Annual Conference Proceedings. Key West, Florida. March 2005.

Libby, Barbara and Vincent Agnello. ''Ethical Dilemmas and the Law, an International Comparison." Presentation and Proceedings at Eleventh Annual International Conference Promoting Business Ethics, DePaul University. Chicago. Illinois, October 2004.

Agnello, Vincent, Peggy Choong, and Daniel Tompkins. "Demutualization of Insurance Companies, Ethical Dilemmas." Presentation and Proceedings at Tenth Annual International Conference Promoting Business Ethics. St. John 's University. Garden City, NY, October 2003.

Libby, Barbara, Vincent Agnello, Audrey Agnello, Mark DeRond, and Nicole Stolowy. "Ethical Dilemmas and the Law, an International Comparison" Presentation and Proceedings at 2003 Hawaii International Conference on Business, University of Hawaii. Honolulu, Hawaii, June 2003.

Agnello, Vincent. "Legal and Ethical Issues of Marketing Bottled Water" Presntation and Proceedings at Ninth Annual International Conference Promoting Business Ethics, Niagara University. Niagara Falls. New York, October 2002.

Agnello, Vincent and Peggy Choong. "HMO Advertising and Physician Capitation: Don't ask, Don't Tell." Presentation and proceedings at Eighth Annual International Conference Promoting Business Ethics. DePaul University. Chicago, Illinois, October2001

Presentation at Conference

Agnello, Vincent. "Getting Past the Basics and Maxim izing Class Time Efficiency: Getting Students to Think and Learn about Business Ethics on Their Own." Presentation at Seventeenth Annual Successful Teaching Conference." Cornell University, Corning, NY October 2009 NYSDEC OHMS Document No. 201469232-00113

Agnello, Vincent, Audrey Agnello, William Angus, Jagat Jain, Anastasia Pikas, Bohdan Pikas. "Student Survey of Effective Teaching Techniques in Business Courses" Presentation at International Conference on Teaching and Leaming, Niagara University, New York, January 2009

Agnello, Vincent. "Getting Past the Basics and Maximizing Class Time Efficiency: Getting Students to Think and Learn about Business Ethics on Their Own." Presentation at Seventeenth Annual Successful Teaching Conference." Cornell University, Corning, NY October 2009

Agnello, Vincent. Keynote speaker at the 2006 Joint Regional PETE Instructor Conference «Building & Maintaining Successful Programs" Sharing Your Success!" Partnership for Environmental Technology Education Community College Consortium for Health an.d Safety Training PETE/CCCHST Conference hosted by Niagara County Community Col.lege and held in Lockport, NY, March 2006.

Agnello, Vincent. "Internationalizing Business Programs through Networking" Presentation at Emerging Issues in International Accounting, Niagara University. Niagara Falls. Canada, August 2002.

Grant Applications:

2 J$I Century Fund Grant Application December 15, 2005. Application to obtain $100,000 grant for the Family Business Center. (Funding denied)

SERVICE (from 2000 to present)

University level

Promotions and Tenure Committee. Fall 2004 - 2008, 1999-2000. 2010-2014

Sabbatical Leave Committee 2008-2014

Associate Marshal - Commencement & Freshmen Convocation 2012-Present

Hearing Committee - Niagara University 2008-2009

Salary Adjustment Committee 2007

Middle States Sub-Committee Chair- Internal Controls. 2006-07

College Level

Director, Niagara University Family Business Center. Spring 2003- Present

Member. College of Business COM Committee 2013-Present

Member, College of Business Quality Assurance Committee (QAC) 2009-20 l 3

Assigned duties: Ethics Assurance Learning Report NYSDEC OHMS Document No. 201469232-00113

Community Involvement and Engagement Report

Member, College of Business Mission. Research, and Faculty Development Committee. 2008 - 2009

Chair, College of Business Mission, Research, and Faculty Development Committee. 2002- 2008

Chair, College Strategic Planning Committee. 2003-2008 Interim Dean, College of Business Administration. 2001-2002

Department Level

Acting Chair, department of Accounting- Spring 2007 and Summer 2013

Member, Accounting Advisory Committee (2012 - Present} Co-Chair, Strategic Planning sub-committee

Created Syllabus for new course: LAW 680 Healthcare Law and Ethics (Fall 2013)

Created Syllabus for new course: BUS 376 Small Business Employment & Management Issues (Spring 2012)

Community

(see Leadership above)

Presented variety of Ethics lectures ( 1.5 hours each) for CPE credits for IAA - Independent Association of Accountants {November 7, 2008, November 5, 2009, and November 3, 2012)

Entrepreneurial Training Program -Assisted in developing, managing a twelve week entrepreneurial program developed for the City of Niagara Falls and ReNU November2009- February 2010

OTHER ACTIVITIES

Moderator - U.S. Army Corps of Engineers/LOOW-RA B Elected Leaders Forum March 2 I, 2009

Television Interview: Gennan Television station ZDF/3 Interview regarding the toxic waste and radioactive problems facing the Niagara community for. kulturzeit ("time of the arts"), a multi award­ winning daily 40-rninute arts-show aired in Gemrnny, Austria and Switzerland on August 4, 2008.

Theology Under the Taps "Stewardship and Sustainability" Panelist with Dr. Mark Gallo and Dr. William Edwards Niagara University November I 0. 20 I 0.

Updiued 916120 J-1 NYSDEC OHMS Document No. 201469232-00113 NIAGARAt UNIVER511Y /:amily Business Center

Memo

To: Nils Olsen

From: Vincent Agnello

Date: November 10, 2014

Re: Toronto Developer

Fact: In Spring 2006 Toronto Developer tock steps to build a five story 92·unlt condominium on a site on the north stde of Old lake Road on lake Ontario and known locally as the Old Club Lakewood Property In the Town of Porter and adjacent to Fort Niagara State Par1t.

Fact: The proposal was from Jedidiah, Inc. and led by developer Paul Oulahen.

Fact: At that.time, I was the President of Residents for Responsible Government, Inc. fighting Chemical Waste Management's application for relicenslrag of RMU·l and application for a new toxic landfill RMU-2.

Fact: While I attended a meeting in the Town of Porter Town Hall I was approached by the developer of the site and asked about RRG and resident concerns. We arranged to speak, by phone, a few days later.

Fact: During that conversation I spoke about the Town of Porter hosting the only commercial toxic waste landfill Jn the entire northeast of the United States and that CWM accepted wastes from 30 states, canada, and Puerto Rico. I advised him that residents were concerned about the cancer rates reported by the State health Department. I told him that while we have tried everything to stop the new landfill. I was scared to death that the State would soon grant a permit for a new toxic landfill on CWM's propertv located .9 miles from Lewiston Central School buildings.

Fact: The developer thanked me for letting him know of the Issues being faced In the Youngstown area. He also told me that he was going to walk away from developing the Lakewood propertv. He did not want to invest in any area that had such problems because the negative publicity of CWM being granted a permtt for a new toxic landfill would negatively affect the values of his project and the values of the proposed condominiums.

Fact: To my knowledge, the developer did not proceed any further on this development project.

~ · ~ Vincent Agnello

P.O. 80Jt 1817 Nwwv. UNNERSIN, NY 14109 P1<0Nfi: 716·286·8160 FAX: 716·286-8206 V.\\l\V,NIAGAAA.ED!JIFBC NYSDEC OHMS Document No. 201469232-00113

EXHIBIT 11 NYSDEC OHMS Document No. 201469232-00113

KENNETH ACKS EDUCATION: THE NYU STERN GRADUATE SCHOOL OF M.B.A. Finuncc, October 1988 BUSINESS ADMINISTRATION THE UNIVERSITY OF CHICAGO B.A. Economics and History, June 1977 WORK HISTORY:

0 1990-present The Cost-Benefit Group LLC (w11•H .co.wbmefitgroup.com)1 f ormerly Damage Valuation Associates • Founder and chiefexecutive ofeconomic consulting and real estate analysis Jinn which produced studies of more than 900 projects wonh over $3.5 billion dollars in 140 counties and 28 states. Finn focuses upon estimating the economic impacts of environment.al hazards upon real estate. and has provided a wide range of other consulting services. • Worked with lhe U.S. Environmental Protection Agency and ERG Inc. to help create cost-benefil and valuation databases and analysis systems. • Analyzed the effects ofnuclear power plants, gasoline storage tanks, asbestos, i.,rroundwater contamination, oil leaks, construction projects, and utility rates upon property values, employment, income, corporate balance sheets, real estate markets, and municipalities. • Valued contaminated propcnics. office buildings. shopping centers, hotels. apartment buildings, vacant land, mobile home parks, automobile dealerships, warehouses. factories. nursing homes, and marinas from Toronto Canada, to Los Angeles California, and to Tampa Florida, including more lhan 50 in Manhallan. • Conducted acquisition reviews, ma.rket analyses. and feasibility studies. • Prepared 135 page rep on on the New York City economy and real estate market to oulline loan ponfolio risks faced by current and prospective stockholders ofNorth Fork Bank. • Monitor, model, and forecast regional economic and financial developments. • Designed and estimated Econometric and lnput/Output models. • Created the ACB Cost Benefit Analysis Software. which can significantly reduce the time and costs for determining impacts. • Furnished litigation support to more than 30 law !inns regarding over 50 cases. • Testified as eitpert witness before the Supreme Court ofthe State ofNew York. a Superior Court in Morris County, NJ, and Lhe NY City Council. • Analyzed Costs and Benefits ofGreen Buildings. Green Roofs, Brown fields and Real Estate Development Projects. • Health care valuations/feasibility studies/market analyses of hospitals, nursing homes and assisted living facilities in Anapolis. MD: Cambridge ancJ Peabody MA, Cape May and Montville NJ; and Brooklyn. Chester, Forest Hills, Plainview, Port Jefferson, and Syracuse NY • Estimated impacts upon property values of contamination for •residences in Brockpon, Great Nl!ck, New Hyde Park. and Lindenhurst, NY; Alloway. Jersey City, and Redbank NJ; Montgomery. AL, Town of Pines Indiana • commercial properties in Bedford, Cammack, Fishkill, Plainview. Ronkonkorna, Sag Harbor, and Valley Stream, NY, Jersey City and Ridgewood, NJ, and East Stroudsburg and Nesquehoning. PA • The above projects were commissioned by J.P. Morgan Chase. Citibank, HSBC. the Bank of Montreal, GMAC, Xerox, US Environmental Protection Agency. US Depl. of Housing and Urban Development, the Federal Deposit Insurance Corpomtion, Chinese American Bank, Amerasia Bank, National Amusements Inc .• Grubb and Ellis, Landauer Realty, the Related Companies, the New York State Housing Finance Agency. The New York City Dept. of Housing Preservation & Development, Nassau and Suffolk Counties, the City of New Orleans, Jersey City, Federated Department Stores, Sheraton Hotels, Techlaw Inc., and over 40 law firms. • Created the Environmental Valuation & Cost-Benefit Website WW\V.costbeneli1anal}'.sis.or2, {folTilerly www.dan1agevaluation.com)http:i/www.dam;ict.:valm1lion.com which has drawn more than 63.000 visitors, been recognized as a respected source of information by numerous organizations with links and fovorable mentions, achieved good search engine placement, and generated new business. 1994-present Editor and Publisher, En.viro11nre11tal Damage Valuation tmd Cost Benefit News (n•ww.e11••imval11a1fo11.11rl!)

THE COST-BENEFl'f>cCROUP, LLC 91 NYSDEC OHMS Document No. 201469232-00113

• Design, edit and market an acclaimed newsleuer, with paid subscribers in ten nations, including in fluential environmental policy makers. In recognition of its merits, the United States EPA and other organizations have devoted space on websites to back issues. • Created the Environmental Valuation & Cost-Benefit News Website and Newsfeed (October, 2005). According to A WSTATS, From July I, 2005 through December 31 , 2005 our sites welcomed an average of 15,440 unique visitors per month, who made a total of 197,219 visits and viewed 1,809,095 pages. 3,!02 ofour visitors felt that Lhe site was worthy ofa bookmark; l I ,128 spent between 5 and 15 minutes on the site; 10,865 between 15 minutes and 30 minutes, 15, 737 between 30 minutes and I hour, and 22,719 spent more than an hour on-site. The Hit Count was 2,708,308. Site has achieved top, top live or top fifteen Google Search status for such keywords as cost- benefit, environmental economics, cost-benefit analysis, and cost-bcnelit green buildings, brown fields, green roofs, ... Among those linking to the site have been the United States Environmental Protection Agency, Environment Canada, the Association of Environmental & Resource Economists, Resoun:es for the Economists on the Internet, Lhe National Association ofBusiness Economists, www.cnv-econ.net, the ISO 14000 Information Center, the Centre for Ecological Sciences of the Indian lnstitute of Science,. . • Created unique Internet marketing campaign, including a "virtual intem" program. Ten interns located throughout the United States have written articles, and assisted with advertising and distribution to more than 8,500 decision makers in 65 countries through a variety of avenues. 1986-1988 Senior A11a~vst, Soutlimark /11<:, • Structured $80 million in real estate syndications, published forecasts ofthe structure and perfonnance oflocal and regional economies in 7 states; and analyzed legal documents. 1984-1986 Project Coordinator, NYC Departme11t ofHousing Preservatiott and De~·elopment • Analyzed, negotiated and underwrote loans for the rehabilitation and development of real estat.e; expedited government approvals including environmental reviews; monitored legislation/determined impacts; supervised the creation and implementation of databases; and assisted attorneys in closing loans and reviewing documents. The loans played a significant role in revitalizing neighborhoods. 1977-1982 Research Assistalll, /11ter11atim1ul Research Department Federal Resen•e Bank ofNY • Monitored and forecnsted economic developments and produced special studies of capital flows, trade, exchange rates, interest rates, housing finance and money supply. PUBLICATIONS/SPEAKING: • "A Framework for Analyzing the Costs and Benefits of Green Roofs: Preliminary Results" Seminar presentations and article for the Columbia University Earth Institute, Columbia University School of International and Public Affairs, NASA Goddard Institute for Space Studies. and New York Environmental Infrastructure Study (2004- 2006) • "Tools for Resolving Community Opposition to Public Projects" Real Es/ate Review (Winter, 1995) • "Shooting In the Dark -- How Computer Software Can Improve the Quality of Government Policies" The Engineering Economist (Spring, 1995) • "Environmental Values" Carnegie Council on Ethics and International '1/fairs (May, 1998 speech) • "Measuring and Evaluating the Environment & Its Effects on Health" (March 25, 1999 speech al The Ethyl R. Wolfe Institute for the Humanities in cooperation with the Environmental Studies Program of Brooklyn College of the City University of New York) • Valuation of Environmental Damages to Real Estate; The Benefits and Costs ofCrime Policies; International Real Estate Investment and Political Risk; Simultaneity Bias & Specilicntion Error from the Omission ofSocio-political factors in Economic Models; Cognitive Dete.rminantsofl luman Capital Investments and Productivity; Complexity, Change, and Economic Analysis; • An Econometric Model of Political, Social and Econometric Change in Britain from 1895 to 1980 COMPUTER SKILLS: Proficiency in using Lotus, Argus, Excel, Project, HTML (Website Design), Windows, G, and several database, econometric, and word processing computer programs. Computer models/programs have been used to discount cash flows, to estimate internal rates of return, to fore.cast regional economic growth, to create a website, to track client contact, and to estimate the impacts of government policies upon employment and income.

PROFESSIONAL AFFILIATIONS/COMMUNITYACTIVITIES: '

THE COST-BENEFJ'f,)eROUP, LLC 92 NYSDEC OHMS Document No. 201469232-00113

Fellow. World Innovation Foundati on. \\'WW.thewif.org.uk, an independent international think tank consisting of 2.000 individuals, including 60 Nobel Prize winners. providing advice regarding scientific, technological, engineeri11g and applied economics matters to non-aggressive governments and corporations, and designing, building and operating an Open Research Establishment featuri ng Lab-Oratories and Incubators throughout the world American Economic Association: Association of Environmental and Resource Economists: New York Association of Business Economists; National Association of Forensic Economists Coach/Manager Long Beach Lillie League. Recreational Basketball 1997-2002

Additiorol: Appraisal Cou.-,cs 5 AIJD for Phd Ecooomics NYU Confen:ncc speaking

T HE COST-BENEF l t)~ROUP . LLC NYSDEC OHMS Document No. 201469232-00113

EXHIBIT 12 NYSDEC OHMS Document No. 201469232-00113 CURRICULUM VITAE

Kirsten B. Moysich

OFFICE: HOME: Roswell Pork Cancer Institute 158 Ruskin Rd. Department of Concer Prevention and Control Amherst. NY 14226 Elm and Carlton Streets (716) 835-2192 Buffalo, NY 14263 (716) 845-8004 fax: (716} 845-841126 e-mail: [email protected]

EDUCAT!ON

1988- 1992 B.A. (summa cum laude }, Psychology State University College of New York at Buffalo

1992-1994 M .S. , Epidemiology Stote University of New York at Buffolo Thesis: The relationship between estrogen replacement theropy use and risk of postmenopausal breost cancer !Advisor: Jo L. Freudenheim. Ph.D.)

1994-1996 Ph.D., Epide miology ond Community He alth State University of New York at Buffalo Dissertation: Environmental organochlorine exposure and risk of breost cancer in postmenopausal women (Advisor: Jo L. Freudenheim, Ph.D.)

AWARDS AND HONORS

1988- 1992 Rudolph International Scholarship 1990 International Student Award; State University College of New York at Buffalo 1990- 1992 Psi Chi Honor Society 1997 Young Investigator Aword; American Association for Cancer Research Best Student Abstract Award; International Society for Environmental Epidemiology Dean's Award for Outstanding Dissertation Research; State University of New York at Buffalo 2002 Young Alumnus Achievement Aword; State University College of New York at Buffalo 2004 Academic Service Award; State University of New York at Buffalo, School of Public Health and Health Professions NYSDEC OHMS Document No. 201469232-00113 RESEARCH AND ACADEMIC EXPERIENCE

1992 - 1996 Research Assistont, Social and Preventive Medicine, State University of New York at Buffalo, Buffalo NY. 1996-1998 Postdoctoral Fellow, Social and Preventive Medicine, State University of New York at Buffalo, Buffalo NY. 1998. 2003 Assistant Member, Department of Cancer Prevention, Epidemiology, and Biostatistics, Roswell Park Cancer Institute, Buffalo, NY. 1998- 2005 Research Assistant Professor. Department of Social and Preventive Medicine, State University of New York at Buffalo, Buffalo NY. 1999-2004 Assistant Professor, Department of Experimental Pathology, Roswell Park Cancer Institute, Buffalo NY. 1999-2.004 Associate Scientific Director, International Consortium far Research an Health Effects of Radiation. 2003-2009 Associate Member, Department of Epidemiology, Roswell Park Cancer Institute. Buffalo NY. 2004-2009 Associate Professor, Department of Cancer Pathology and Prevention, Roswell Park Cancer Institute, Buffalo NY. 2005- 2009 Research Associate Professor, Department of Social and Preventive Medicine, State University of New York at Buffalo, Buffalo NY. 2006-2009 Associate Professor of Oncology, Roswell Park Cancer Institute, Buffalo NY. 2007 - present Professor (Honorary), Faculty of Health, University of Central Lancashire, Preston, United Kingdom 2009- present Full Member, Department of Cancer Prevention and Control, Roswell Park Cancer Institute 2009 - present Professor of Oncology, Roswell Park Cancer Institute 2009 - r;resent Professor, Department of Cancer Pathology and Prevention, Roswell Park Cancer Institute, Buffalo NY. 2009 - present Research Professor, Department of Social and Preventive Medicine, State University of New York at Buffalo, Buffalo NY. 2010- present Chair, Department of Cancer Pathology and Prevention, State University of New York at Buffalo, Buffalo NY. 2012- present Professor of Tumor Immunology, Roswell Park Cancer Institute. Buffalo NY.

2 NYSDEC OHMS Document No. 201469232-00113 GRANT SU PPORT

Current

P50CA159981-01 (Odunsi) 09/13-8/18 253 NIH/NCI RPCl-UPCI Ovarian Cancer SPORE Role: Co-Pl. Co-Leader Administrative Core. Co-Leader Developmental Research Program. Co-leader Project 4 The gaol of the RPCl-U PCI Ovarian Cancer SPORE is to identify novel immunotherapeutic modalities ta improve clinical outcomes for newly diagnosed and recurrent ovarian cancer patients.

ROl CA 126841-04 (Moysich) 07 /09-06/14 253 NIH/NCI Regulatory T Cell Function in Ovarian Cancer Annual Direct:$484, 1 45 Role: Pl To tal Direct: $2,635,732 The goal of this study is ta determine the role of genetic variability in regulatory T cell function in the etiology and prognosis of ovarian cancer.

Supplement to ROlCA 126841-04 (Moysich) 04/11-08/14 (NCE) 53 NIH/ NCI (donated) Genetic polymorphisms in cortisol pathway and ovarian cancer Role: Pl The purpose af this study is to investigate genetic polymorphisms in cortisol pathway and ovarian cancer.

No Number Assigned (Moysich) 09 /l 3-08/l 4 53 Roswell Pork Alliance Foundation (donated} Development of innate immune responses in the tumor microenvironment as a prognostic signature for progression-free survival in women with advanced epithelial ovarian cancer Role: Pl The purpose of this study is to examine the prognostic significance of immunosuppressive b iomarkers in women with advanced ovarian cancer.

No Number Assigned (Eng) 09I13-08/14 53 Roswell Park Alliance Foundation (donated} Pilat study of personalized treatment markers in recurrent ovarian cancer Role: Co-lnvestiQator The purpose of this study is to genera te preliminary data on the associations between clinical and genetic characteristics and treatment outcomes among women with ovarian cancer.

3 NYSDEC OHMS Document No. 201469232-00113

COl 9286 (Marshall) 09/88-09/13 153 NYS DOH Improving Cancer Surveillance and Reporting Annual Direct: $80,000 Role: Co-Investigator Total Direct: $800.000 The objective of this effort is to identify common risk factors for solid and hematological malignancies.

R25CA 113951-06 (Freudenheim/Moysich) 07/12-06/1 7 53 NCI/NIH Interdisciplinary Training in Cancer Epidemiology at UB Role: Multiple Pl

The goal of this training grant is to provide interdisciplinary training in cancer epidemiology ta doctoral students at the University at Buffalo and the Graduate Division of the University of Buffalo at Roswell Park Cancer Institute

Pending

1RO 1CA188900-01 (Segal/Moysic h) 7/14 - 6/19 203 NIH/NCI Novel immunological biomarkers in ovarian cancer prognosis Role: Multiple Pl The objective of this study is to investigate previously unexplored immune function markers in ovarian carcinogenesis.

Previous

BCTR0706811 {Moysich) 04/07-11 /12 153 Susan G. Komen Foundation Regulatory T Cells and Breast Cancer Risk Annual Direct: $80.000 Role: Pl Total Direct: $300.000 The objective of this research effort is to critically evaluate environmental risk factors for breast cancer and identify gaps in our current understanding of breast cancer etiology.

R03 CA 121881-01A1 (Moysich) 12/06-l l I l o 103 NIH/NCI Pharmacogenefics in Ovarian Cancer Annual Direct: $50,000 Role: Pl Total Direct: $ J 00,000

The goal of this study is to determine the utility of stored tumor samples tor large-scale pharmacogenetic studies in ovarian cancer.

4 NYSDEC OHMS Document No. 201469232-00113 5R01CA095023-02 (Ness} 04/03-03/09 53 NIH/ NCI Inflammation and Ovarian Cancer Annual Direct: 103,281 Role: Site Pl Total Direct: $598.727

The goal of this multi-site population based ca se-control study is to explore the role of inflammation in ovarian cancer etiology.

N0008081 (Odunsi) 03/08-02/ 1 I 103 DoD Ovarian Cancer Research Foundation Approaches For Enhancing Tumor Immunity In Ovarian Cancer Annual Direct: $73.497 Role: Pl (Proiect 41 Total Direct: $270,931 The goal of this study is to determine the role of genetic variability in regulatory T cell function in the etiology and prognosis of ova rian cancer.

No Number Assigned (Chanan-Khan) 04/08-08/ l 0 53 Roswell Park Cancer Institute Alliance Foundation Targeting the Immunological Microenvironment in Annual Direct: $69,984 (Donated) Multiple Myeloma Total Direct: $69.984 Role: Pl Project 5 The goal of this project is to determine the significance of regulatory T cells in the etiology of multiple myeloma.

R03 HD059556-01 (Erwin) 07 /08-06/ I 0 33 Arts. Research, T-cells & Socio-demographics (ARTS) in the Niagara Region Annual Direct: $50.000 Role: Co-Investigator Total Direct: $100.000 The objective of this study is to test the feasibility of the enrolling racially and soc iodemogrophically diverse participants in on epidemiological study of immune function.

No Number Assigned (Shrikant) 01 /1 0 - 12/1 0 53 Roswell Park Cancer Institute Alliance Foundation Development of an Ovarian Canc er SPORE Application Annual Direct: 150.000 (Donated) Role: Pl Project 2 Total Direct: $150,000 The purpose of project 2 is to evaluate the utility of the fllumina methylation chip in epigenetic studies of ovarian ca ncer.

No Number Assigned (Gelman) 01 I 1o - 12/ 1o 33 Roswell Pork Cancer Institute Alliance Foundation Genetic signature for progression o f Borre1t's esophagus (Donated) to esophageal adenocarcinoma Annual Direct: 150.000 Role: Co-Investigator Total Direct: $150.000 The objective of this research is to identify a genetic signature far progression of Barrett's esophagus to esophageal adenocarcinoma.

No Number Assigned (Sucheston) 10/2008- 04/2010 53 Roswell Park Cancer lnstituf e Alliance Foundation Effect Modifier Genes in Ovarian Cancer Annual Direc t: 100,000 (Donated} Role: Co-Investigator Total Direct: $100,000

5 NYSDEC OHMS Document No. 201469232-00113 Goal is to identify genetic variants that modify the effects of BRCA 1, BRCA2 on the odds of ovarian cancer using genome wide data on germline genetic variation in Gilda Radner Ovarian Family Cancer Registry Participants.

C021337 (Moysich} 09 /06-08/09 53 NYSDOH Gene-Environment Interactions in Breast Cancer Annual Direct: $60,000 (Donated} Role: Pl/Mentor !Trainee: Ji-Yeob Choi) Total Direct: $120,000

The purpose of this effort is to conduct secondary analyses of the influence of genetic polymorphisms on the associations between epidemiological risk factors and breast cancer risk.

No Number Assigned (Odunsi) 01/06 -12/07 53 Roswell Park Ca.ncer Institute Alliance Foundation Development of Novel Detection and Treatment !Donated} Strategies for Ovarian Cancer Annual Direct: $30,000 Role: Pl Project 3 Total Direct: $30,000 The goal of this research is ta conduct a comprehensive analysis of functional genetic polymorphisms associated with activity of Treg cells in ovarian cancer.

IRG-02-197-04 (Moysich/Still) 01 /06-4/08 53 American Cancer Society Association of TACC3 Polymorphisms and Ovarion Annual Direct: $25,000 (Donated} Cancer Risk Total Direct: $25,000 Role: Pl The goal of this research is to evaluate the role of TACC3 polymorphisms in the etiology of ovarian cancer. No Number Assigned (Brody) 10//04-09 /07 103 Susan G. Komen Foundation Environmental Factors in Breast Cancer Annual Direct: 47,084 Role: Co-lnvestioator Total Direct: $1 54, 723 The objective of this research effort is to critically evaluate environmental risk factors for breast cancer and identify gaps in our current understanding of breast cancer etiology.

No Number Assigned (Moysich) 04/05-03-07 53 Roswell Park Cancer Institute Alliance Foundation Phormacogenetics and Ovarian Cancer Prognosis Annual Direct:$30,000 Role: Pl Total Direct: $30,000 The purpose of this pilot study is to investigate the prognostic significance of genetic polymorphisms relevant in the metabolism of chemotherapy among ovarian cancer patients.

5R03CA108353-02 (Moysich) 04/04-03/07 103 NIH/NCI Use of Stored Bone Marrow Samples for Annual Direct: $50,000 Pharmacogenetic Studies of Acute Myeloid Leukemia Total Direct: $100,000 Role: Pl The objective of this research is to determine the appropriateness of stored bone marrow samples from large biological specimen banks for pho.rmacagenetic studies of hematological cancers.

6 NYSDEC OHMS Document No. 201469232-00113 No Number Assigned (Lavender) 09 /03-08/06 53 ATSDR University-Community Consortium for Anniston Annual Direct: $5,645 Environmental Health Research Total Direct: $18,645 Role: Co-lnvestiQator The purpose of this research consortium is to develop and carry out research studies a imed to assess health effects among ind ividuals exposed to very high levels of palychlorinated biphenyls.

NIH/ NICHD contract (Moysich) 09/01-12/05 53 Intrauterine Irradiation Exposure and Adult Fecundity and Fertility Annual Direct: $50,000 Role: Pl Total Direct: $80,000 The objective of this study is to examine early fife radiation exposure in relation to subsequent reproductive health indicators.

No Number Assigned {Michalek, Moysich) 04/99-03/03 303 Office of Naval Research Health Effects of Radiation Resulting from the Chernobyl Accident Annual Direct: 240,000 Role: Co-Pl Total Direct: $960,000 The purpose of this study was to investigate the a ssociation between radiation exposure and risk of acute childhood leukemia in areas of Ukraine most affected by the Chernobyl accident.

No Number Assigned (Moysich) 04/01-03/04 203 Office of Naval Research Post-traumatic stress indicators among individuals exposed to Chernobyl-related radiation Annual Direct: Role: Pl $120,000 Total Direct: $360,000 The goal of this research effort is to assess the feasibility of conducting a large-scale epidemiological study on psychological health in three republics of the former Soviet Union.

No Number Assigned (Michalek) 04/01-03/04 53 Office o f Naval Research Establishment of a Comprehensive Cancer Registry in Ukraine and Belarus Annual Direct: 120,000 Role: Co-lnvestiQator Total Direct: $360,000 The objective of this effort is to support the infrastructure in Ukraine and Belarus to establish a cancer registry in areas seriously affected by Chernobyl related radiation exposure.

NATIONAL PROFESSIONAL SERVICE

2001 - Member of Breast Cancer Coalition of Rochester Advisory Committee 2001 - Member of the New Jersey Comprehensive Cancer Control Plan Advisory Board 2003 - 2007 Member of AACR Molecular Epidemiology Group Outreach and Membership Committee

7 NYSDEC OHMS Document No. 201469232-00113 2003- Member of the External Advisory Group for the Centers of Excellence in Children's Environmental Health and Disease Prevention Research, Mount Sinoi School of Medicine. New Yark. NY 2004- Member of the External Advisory Group for the University of Iowa Superfund Basic Research Program, Iowa City, Iowa 2006- Member, California Breast Cancer Research Program Special Research Initiatives Strategy Committee 2007 - Member, Scientific Advisory Boord for the Sister Study, Notional Institute of Environmental Health Sciences 2009 - Member, Scientific Advisory Board, Exposure and Human Health Committee, U.S. Environmental Protection Agency 2008- Member. Ovarian Cancer Association Consortium 2010 - 2013 Member, Data Access Committee, Ovarian Cancer Association Consortium 2013- Chair, Doto Access Committee, Ovarian Cancer Association Consortium

PROFESSIONAL MEMBERSHIPS

American Association for Cancer Research American College of Epidemiology International Society for Environmental Epidemiology Molecular Epidemiology Group Women in Cancer Research

SCIENTIFIC PEER REVIEW

Journals - Ad hoc reviewer

American Journal of Epidemiology American Journal of Industrial Medicine Annals of Epidemiology Archives of Environmental Contamination and Toxicology Archives of Medical Research BMC Cancer Breast Cancer Research Breast Cancer Research and Treatment Cancer Cancer Causes and Control Cancer Epidemiology, Biomarkers & Prevention Cancer Genetics and Cytogenetics Cancer Research Carcinogenesis Chemica Biological Interactions Clinical Cancer Research Epidemiology Environmental Health Perspectives Environmental Research Immunological Investigations International Journal of Cancer International Journal of Occupational ond Environmental Health Journal of the American Medical Association

8 NYSDEC OHMS Document No. 201469232-00113 Journal of the National Cancer Institute Journal of Nutrition Journal of Oncology Lancet Oncology Pharmacogenetics Phormacogenetics and Genomics Tobacco Control

Editorial Board Cancer Genetics and Cytogenetics

Grant Review

2002 Breast Cancer Coalition of Rochester Grant Review Panel Research Secretariat at the Workers' Compensation Board {WCBl of British Columbia Grant Review Committee CDMRP Breast Cancer Research Program, Epidemiology Review Panel 2003 Canadian Breast Cancer Research Initiative Review Panel CDMRP Ovarian Cancer Research Program. Epidemiology Review Panel National Cancer Institute U.S. Radiologic Technologists Cohort Review Panel National Cancer Institute, Specialized Program af Research Excellence (SPORE) in Ovarian Cancer Review Panel National Cancer Institute. Specialized Program of Research Excellence (SPORE) in Leukemia and Lymphoma Review Panel 2004 CDMRP Ovarian Cancer Research Program. Epidemiology Review Panel National Cancer Institute. Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer Review Panel California Breast Cancer Research Program Etiology and Prevention Review Panel National Cancer Institute Early Detection Research Network (EDRN}: Clinical Epidemiology and Validation Centers Review Panel Science and Technology Assistance Agency, Slovakia: External Grant Reviewer 2005 California Breast Cancer Research Program Etiology and Prevention Review Panel National Cancer Institute, Small Grants far Behavioral Research in Cancer Control Review Panel (July) National Cancer Institute, Small Grants far Behavioral Research in Cancer Control Review Panel (November) 2006 California Breast Cancer Research Program Etiology and Prevention Review Panel National Cancer Institute Radiation Epidemiology Branch Site Visit Review Panel 2007 California Breast Cancer Research Program Etiology and Prevention Review Panel Susan G. Kamen for the Cure Focused Areas of Study Program Review Panel CDMRP Ovarian Cancer Research Program. Concept Awards Review Panel National Cancer Institute Subcommittee H, Cancer Treatment Cooperative Groups 2008 CDMRP Ovarian Cancer Research Program, Epidemiology Review Panel

9 NYSDEC OHMS Document No. 201469232-00113 2009 Member. Susan G. Komen for the Cure Research Programs. Epidemiology & Risk Assessment Study Section National Institute of General Medical Sciences Research and Research Infrastructure Grand Opportunities (RC2J Review Panel 2010 Member, National Cancer Institute Subcommittee J - Population and patient­ Orientated Training Review Group 2011 Chair. California Breast Cancer Research Program Etiology and Prevention Review Panel Member, National Cancer Institute Subcommittee J - Population and patient­ Orienfated Training Review Group 2012 National Cancer Institute. Specialized Program of Research Excellence (SPORE) Review Panel Chair, California Breast Cancer Research Program Etiology and Prevention Review Panel Member, National Cancer Institute Subcommittee J - Population and patient­ Orientated Training Review Group Reviewer, Marsden Fund of New Zealand 2013 Member, National Cancer Institute Subcommittee J - Population and patient­ Orientated Training Review Group

INVITED SEMINARS AND SYMPOSIA

1997 Department of Internal Medicine. Sister's of Charity Hospital, Buffalo. NY Toxicology Research Center, University at Buffalo. Buffalo. NY. Chlorine Chemistry Council, Arlington. v A. 1998 Graduate Center for Toxicology. University of Kentucky, Lexington. KY. Department of Social and Preventive Medicine, University at Buffalo, Buffalo, NY. 1999 Department of Cancer Prevention, Fred Hutchinson Cancer Institute, Seattle WA. 2000 Department of Medicine, Roswell Pork Cancer Institute, Buffalo New Yark. PCB Workshop, University of Ken tucky, Lexington, KY. International Society of Environmental Epidemiology, Buffalo, NY. Deportment of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY. 2001 Social and Preventive Medicine. University at Buffalo, Buffalo, NY. Department of Psychology, Buffalo State College, Buffalo, NY. Department of Cancer Prevention, Mount Sinai School of Medicine, New York, NY. Department of Environmental Toxicology and Health, Cornell University, Ithaca. NY. e.hormone Conference, Tulane University, New Orleans, LA. 2002 Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY. Era of Hope Conference of the Breast Cancer Research Program (BCRP}, Orlando, FL. Marin Breast Cancer Watch, San Francisco, CA. 2003 Medical Scientist Training Program. University at Buffalo, Buffalo, NY. 2004 Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY. AACR Frontiers in Cancer Prevention Conference. Seattle, WA. NYS Regional Cytogenetics Meeting, Buffalo, NY.

10 NYSDEC OHMS Document No. 201469232-00113 2005 National Breast Cancer Coalition Advocacy Training Conference, Washington. DC. National Breast Cancer Coalition- Project Lead. Minneapolis, MN. 2006 National Breast Cancer Coalition Advocacy Training Conference. Washington. DC. National Breast Cancer Coalition - Project Lead, Houston. TX Society af Nuclear Medicine Annual Meeting - SanDiego, CA Desert Research Institute - Environmental Monitoring Meeting- Las Vegas, NV 2007 University of Central Lancashire. Preston. United Kingdom. 2008 University of Iowa, Iowa City, IA National Breast Cancer Coalition - Project Lead, Denver, CO. 2009 International Society for Environmental Epidemiology. Dublin, Ireland. National Breast Cancer Coalition, San Diego, CA Medizinische Hochschule Hannover (MHH), Hannover. Germany 201 O University of Rochester. Rochester, NY Cambridge University, Cambridge, United Kingdom Mayo Clinic, Rochester, MN Deutsches Krebsforschungs Zentrum (DKFZJ, Heidelberg. Germany 2011 Karalinska Institute. Stockholm Sweden Ovarian Cancer Association Consortium, Stockholm Sweden National Breast Cancer Coalition - Project Lead, Lo Jolla, CA University of Iowa, Iowa City, IA 2012 Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY Division of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, NY Ovarian Cancer: Prevention, Detection and Treatment of the Disease and Its Recurrence, Pittsburgh, PA 2013 Medizinische Hochschule Hannover (MHH), Hannover, Germany

TEACHING EXPERIENCE

Courses

1995-1996 Biostatistics. Epidemiology. and Preventive Medicine (SPM 600) Small Group Instructor 1998- Cancer Epidemiology (PTR 525) 1999 Investigation of Cancer Clusters (SPM 599) 2004 Environmental Epidemiology Care Segment in Epidemiologic Applications to Environmental Health (SPM 551) 2013- Cancer Prevention and Control (PTR 500}

Lecture~

1996- 1997 Descriptive Epidemiology, SPM 501 Principles of Epidemiology 1996 - 1997 Breast Cancer Epidemiology, RPN 525 Cancer Epidemiology. 1999 - Epidemiologic Methods in Cancer Research. RPN Oncology for Scientists 1999- Authorship, RPN Ethics Seminar 1999 Gene-Environment Interactions, SPM 501 Principles of Epidemiology 1999- Epidemiological Study Designs, RPN Research Methods Seminar. 2000- 2003 Environmental Effects on Health, PTR 535 Pathophysiology 2001 Oncoqenesis, PMR 515 ~ Principles of Cancer Chemotherapy

l l NYSDEC OHMS Document No. 201469232-00113 2003- Basic Cancer Biology, SPM 560- Biological Basis of Public Health 2005- Authorship, RPN 602 - Analysis of Health Related Data 2005 Heolth Effects of Radiation, SPM 551 - Epidemiologic Applications to Environmental Health 2005- Molecular Epidemiology, PTR 500 - Cancer Control and Prevention 2005- Cancer - Magnitude of the Problem, RPN 500 - Oncology for Scientists 2005- Cancer Epidemiology - RPN 500-0ncology for Scientists

MENTORING ACTIVITIES

Postdoctoral Fellows

2000- 2002 Helen Swede. Ph.D. 2006 - 2007 Jun Yang. MD, Ph.D 2007 - 2009 Ji-Yeab Choi. Ph.D. 2008- 2012 Mary Platek, Ph.D.

Clinical Fellows

2006 Jeannine Villella, DO 2009 - 201 O Stacey Akers, MD 2012 - Nicole Hinchy, DDS

Committee Chair

Doctoral Students

1998 - 2000 Helen Swede (Ph.D. in Epidemiology and Community Health, University at Buffalo) -HER2/neu expression and epidemiological risk factors as prognostic factors in primary breast cancer. 1998 - 2002 Jun Yang (Ph.D. in Epidemiology and Community Health, University at Buffalo} - Gelsolin expression, epidemiological risk factors and lung cancer. 2001 - 2005 Julie Baker {Ph.D. in Epidemiology and Community Health, University at Buffalo) Adverse birth outcomes in the offspring of adults exposed to radiation in utera. 2000- 2007 Ravi MeneLes (Ph.D. in Epidemiology and Community Health, University at Buffalo) - DNA methylation patterns as marker of exposure ta carcinogens. 2000- 2007 Joli Weiss (Ph.D. in Epidemiology and Community Health, University at Buffalo} - Genetic variability in response ta treatment among adult leukemia patients. 2004 - 2006 Beth Heavy (Ph.D. in Epidemiology and Community Health, University at Buffalo) - Adolescent Pregnancies: Racial Disparities in Reproductive Decision-Making. 2009 - 2012 Shalaka Hampras (Ph.D. in Cancer Pathology and Prevention, University at Buffalo} 2009 - 2011 Raj Chennamaneni (Ph.D. in Epidemiology and Community Health, University at Buffalo)

Master's Students

1998 - 2000 Chi Hung Wong (Masters in Natural Sciences, University at Buffalo) - A retrospective cohort study evaluating the role of ollogeneic blood or marrow transplantation far Hodgkin's disease. 1998 - 2000 Claudia Leiras {Masters in Natural Sciences, University at Buffalo) - Active and passive smoking in relation to breast cancer risk. 12 NYSDEC OHMS Document No. 201469232-00113 1999 - 2002 Alicia Wiggins (Masters in Natural Sciences. University at Buffalo) - Methods of Contraception and risk of ovarian cancer. 2003- 2004 Saro Lawrence (Masters in Epidemiology, University at Buffalo) Quality of sleep indicators omong individuals affected by the Chernobyl nuclear power plant occident. 2006 - 2007 Jane Ratterman (Masters in Epidemiology, University at Buffalo} - Body mass index and risk of adult AML. 2007 - 2009 Melanie Ruszczyk !(Masters in Epidemiology, University a t Buffalo) - Genetic Variability in DNA Repair Capacity and Ovarian Cancer Prognosis. 2011 - Martha Critelli (Masters in Natural Sciences, University ot Buffalo} - Regulatory T Cells in Multiple Myeloma.

Committee Member

Doctoro/ Students

1998 - 2003 Kimberly Perez (Ph.D. in Epidemiology and Community Health, University ot Buffalo) Reproductive outcomes in men prenatally exposed to diethylstilbestrol. 2001 - 2004 Michael Bloom (Ph.D. in Epidemiology and Community Heolth, University ot Buffalo) The association between serum levels of hexachlorobenzene and thyroxine in a sample of New York State sportsmen; the New York Sta te Angler Cohort Study. 1999 - 2004 Choarou Chen (Ph.D. in Epidemiology ond Community Health, University a t Buffalo) Reproductive Factors and Risk of Ovarian Cancer - Are Controls Really Controls? 2004- 2006 Gregory Beehler (Ph.D. in Counseling Psychology, University of Buffalo) 2004- 2007 Lu ke Peppone Tobacco Exposure over Five decades and Colorectol Cancer risk. (Ph.D. in Epidemiology and Community Health, University at Buffalo} 2006- 2009 Chunqiao Tian (Ph.D. in Epidemiology ond Community Health. University at Buffolo} - Phormacogenetics in Ovorion Cancer. 2006-2009 Vijovvel Joyoprokash Ph .D. in Epidemiology and Community Health. University at Buffalo} Bimodality Screening for Lung and Orol Concers. 2007 - 2010 Theodor Brodsky (Ph.D. in Epidemiology and Community Heolth. University at Buffalo} - Dietary Exposures ond Breast Cancer 2008- 2009 Nataliya Kuptsova {Ph.D. in Cancer Pa thology and Prevention. University at Buffalo) - Genetic Variability in DNA Repair Capacity ond AML. 2012- Nqozi Nwizu (Ph.D. in Concer Pathology and Prevention. University at Buffalo} - Periodontal Disease and Cancer Risk.

Master's Students

1997 - 1999 Jennifer Norton (Masters in Epidemiology, University at Buffalo) - Residential proximity to sources of polycyclic aromatic hydrocarbons (PA Hs) and breost cancer risk. 1998 - 2000 James Thrasher (Masters in Epidemiology, University at Buffalo} - Does family history of colarectal cancer influence the return of fecal occult blood tests in a moss screening compaign? 1998 - 2000 Julie Boker (Masters in Epidemiology, University a t Buffalo) - Fertility patterns prior to testicular cancer diagnosis. 2001 - 2002 Christina Kuo (Masters in Epidemiology, University at Buffalo) - The potential impact of physical activity counseling by western New Yark physicians.

13 NYSDEC OHMS Document No. 201469232-00113 2003 - 2004 Luke Peppone (Masters in Epidemiology. University at Buffalo) - Cigarette Smoking and Risk of Colorectal Cancer 2002 - 2006 Jill Schaefer (Masters in Natural Sciences, University at Buffalo) Tea consumption and colon cancer risk. . 2006-2007 Michael Yeh (Masters in Epidemiology, University at Buffalo) - Diet and Endometrial Cancer Risk. 2007 - 2008 Kellie Demock Masters in Natural Sciences, University at Buffalo) - The role of hypoxia inducible factor and vascular endothelial growth factor receptors in acute myeloid leukemia. 2007 -2008 Patricia Marshall (Masters in Epidemiology, University at Buffalo) - Analysis of a Corporate Compliance Survey at Roswell Park Cancer Institute. 20 13 - Jordon Rabey (Masters in Epidemiology, University at Buffalo) The association between alcohol consumption, supplement intake, physical activity and renal cell carcinoma.

MPH Student Fieldwork Supervisor

2003 - 2005 Abhishek C Sawant 2003 - 2005 Kwabena Boakye 2004-2005 Hyungsun Kim 2004 -2005 Sarah Klein

Summer Students

J 999 Fang Zhou (Groduate Student; University of Massachusetts) - Project: Gelsolin expression in breast cancer. 2000 Adrienne Ronsani (Graduate Student; University of Massachusetts) - Project: Regular ospirin use and lung cancer risk. Christina Costa .{Undergraduate Student, University at Buffalo} - Project: Exogenous and endogenous hormones in relation to lung cancer among women. 2001 Kenneth Huber (Graduate Student; University of Massachusetts} - Project: Regular ospirin use and pancreatic cancer risk. Laura Warlow (Undergraduate Student. Perdue University} - Project: Tubal ligation and breast cancer risk. 2004 Athul Seshadri (High School Senior - Williamsville East High School) - Project: Vitamin D and Prostate Concer Risk. Benjamin Morrison (High School Junior - Brooklyn Friends School} - Project: Inflammation ond Ovarian Cancer. 2005 Robert Niles (High School Senior- Williamsville High School) - Project: Effect of Self-Reported Drug and Alcohol Use on School Performance among High School Students. Benjamin Marrison (High School Senior - Brooklyn Friends School} - Project: Aspirin and Bladder Concer Risk. Elizobeth Livingstone (High School Senior - Stuyvesant High School) - Project: Acetaminophen and Bladder Cancer Risk. 2009 Nickolas Furlani (Case Western University) - Project: Epidemiological Predictors of Regulatory T Cells in Women.

Student Awards

14 NYSDEC OHMS Document No. 201469232-00113 1999 Julie Baker - International Society for Environmental Epidemiology Student Travel Award. Julie Baker - Roswell Park Cancer Institute Graduate Student Research Forum Poster Award. 2000 Helen Swede -American Association for Cancer Research Young Investigator Award. James Thrasher - New York State Public Health Association Graduate Student Research Award. 2001 Julie Baker - NNEMS Fellowship, Environmental Protection Agency. Claudia Leiras - Congress of Epidemiology Student Travel Award. 2002 Claudia Leiras - American Association for Cancer Research Minority Scholar Award in Cancer Research Joli Weiss - Invited participant of the American Association for Cancer Research Pathobio\ogy of Cancer Workshop. Joli Weiss- Invited participant of the International Agency for Research on Cancer Molecular Epidemiology Workshop. 2003 Julie Baker - Summer Research Fellowship - Notional Institute for Child Health and Human Development 2004 Julie Baker - Woodrow Wilson-Johnson & Johnson Dissertation Grant in Women's Health Julie Baker - Francis V Hanavan Award for Students with Great Potential for Future Contributions in the Health Related Professions. State University of New York at Buffalo, School of Public Health and Health Professions. Julie Baker - Association of Schools of Allied Health Professions Scholarship for Excellence Award 2005 Athul Seshadri - Invited participant to the Young Epidemiology Scholars Conference and Regional Semi-Finalist Award -Robert Wood Johnson Foundation and the College Boord. Julie Baker - Invited participant to the 1st Annual NICHD-IHDCYH Summer Institute in Reproductive ond Perinatal Epidemiology, Woods Hole, MA. Julie Baker - LGBT HEART Scholar: National award for students committed to affecting change in the LGBT community through education and work in the health professions. Beth Heavy - Mark Diamond Research Fund grant for research expenses related to conduct of dissertations. State University of New York at Buffalo 2006 Ravi Menezes - Invited participant to the American Association for Cancer Research Edward A. Smuckler Memorial Pathobiology of Cancer Workshop 2007 Julie Baker - Dr. Louis Sklarow/Maimonides Medical Society Award Melanie Ruszczyk - Kosciuszko Foundation Scholarship 2008 Ravi Menezes - Saxon Graham Award for Excellence in Epidemiology and Community Health. State University of New York at Buffalo, School of Public Health and Health Professions 2009 Shalaka Hampras - Invited participant to the UCLA Statistical Genetics Course Raj Chennamaneni- Invited participant to the UCLA Statistical Genetics Course

UNIVERSITY SERVICE

1999 - 2002 Member of Graduate Education Committee - Social and Preventive Medicine. University at Buffalo. 1999 - Member of the Graduate School Faculty, Schoof of Biomedical Sciences, University at Buffalo

15 NYSDEC OHMS Document No. 201469232-00113 1999 - 2007 Member of Preliminary Exam Committee - Social and Preventive Medicine. University at Buffalo. 1999 - 2004 Member of the NCI Training Grant Steering Committee, Social and Preventive Medicine, University at Buffalo - Roswell Park Cancer Institute. 2002- Faculty member of the Medical Scientist Training Program, School of Medicine and Biomedical Sciences, University at Buffalo 2003- Member of Executive Education Committee; Deportment of Cancer Pathology and Prevention, University at Buffalo, Roswell Park Cancer Institute Graduate Division 2003 - Member of Graduate Education Committee - Social and Preventive Medicine, University at Buffalo. 2004 - Member of the Admissions Committee for the Department of Cancer Pathology and Prevention. University at Buffalo, Roswell Park Cancer Institute Graduate Division 2006 Member of Search Committee: Director of Division of Environmental Epidemiology; Social and Preventive Medicine, University at Buffalo. 2009 Member of Search Committee: Environmental Health Faculty; Social and Preventive Medicine. University at Buffalo.

ROSWELL PARK CANCER INSTITUTE SERVICE

1999 - 2002 Council Member of the Association of Scientists 2003- Member, Institutional Review Board 2007- Member. Gilda Radner Familial Ovarian Cancer Registry Executive Committee 2008 Member, Clinical Research Service Advisory Committee 2008 Member. Information Technology Advisory Committee 2008- Member, Roswell Park Alliance Foundation Grant Review Panel (Epidemiology) 2009- Member, Ethics Task Force 2009- Member, Diversity Council 2010- Co-Leader. Gilda Radner Familial Ovarian Cancer Registry 2010- Co-Leader. Disease Site Research Group - Gynecological Oncology 2011 - Member. IT Advisory Committee 2011 - Member. Graduate Education Leadership Committee 2012- Member (ad hoc), Scientific Review Committee 2012- Member, Roswell Park Alliance Foundation Grant Review Panel (Immunology) 2013- Member. Roswell Park Alliance Foundation Grant Review Panel {Health Behavior) 2013- Chair, Data Bank and Biorepository Advisory Committee

COMMUNITY SERVICE

2000 Environmental Exposures and Health Effects among Women and Children. Invited Lecture. Jewish Women on the Threshold of the 2l51 Century, The Jewish Federation. Buffalo, NY Pesticides and Breast Cancer, Invited Lecture, Bosom Buddies Lecture Series, East Aurora, NY Risk Factors for Breast Cancer, Walk and Talk Tour. Roswell Park Cancer Institute Community Outreach Event 2001 Expert reviewer of the Cornell University Program on Breast Cancer and Environmental Risk Factors (BCERF} Environmental Chemicals Fact Sheets

16 NYSDEC OHMS Document No. 201469232-00113 2002 Contributing writer to The Ribbon - a lay publication on research and on the role of the environment in the risk of breast cancer. Contributing writer to MAMM magazine - a consumer publication targeted ta the needs of women diagnosed with breast and reproductive cancer. Epidemiology of Blood-Related Cancers, Invited Lecture, Leukemia and Lymphoma Family Support Group, Buffalo, NY. 2003 Toking Steps to Reduce your Risk of Breast Cancer. Invited lecture at the Buffalo Seminary School. Buffalo, NY. Cancer 101. Invited lecture, Alpha Koppa Alpha Buffalo Chapter. Buffalo, NY. 2004- Scientific adviser for Residents for Responsible Government. Inc; Lewiston, NY Ovarian Cancer. Invited lecture at Temple Beth Zion, Buffalo, NY Environmental Factors and Breast Cancer. Invited lecture at the Buffalo Seminary School, Buffalo, NY. 2005 Ovarian Cancer 101. Invited lecture at the Western New York Gilda's Club. Buffalo, NY. Project Lead Faculty Member. Notional Breast Cancer Coalition. Breast Cancer l 0 l. Invited lecture at the Breast Cancer Network of WNY. Amherst, NY. 2005- Scientific Advisor for the Lewiston-Porter School District Teachers Association, Lewiston, NY 2006- Member of the Healthcare Advisory Council- Gilda's Club Western New York 2006 New Developments in Breast Cancer. Invited lecture for the WNY Susan K. Komen Foundation Chapter, Buffalo, NY. Risk Factors for Breast and Ovarian Cancer. Invited lecture at the Gilda's Club Capitol Region New Yark. Albany, NY 2006- Member of the Tobacco-Free-School Policy Committee - Kadimah School of Buffalo, Amherst. NY 2007 Breast Cancer 101. Invited lecture at the Buffalo Executives Association. Buffalo, NY 2008 Breast Cancer 101. Invited lecture of the Buffalo Seminary School. Buffalo, NY. Epidemiology l 01. Invited lecture at the Lewiston-Porter School District, Youngstown. NY. 2009 Project Lead Faculty Member. Notional Breast Cancer Coalition. 2010 Project Lead Faculty Member. National Breast Cancer Coalition. 2011 Project Lead Faculty Member. National Breast Cancer Coalition.

REFEREED PUBLICATIONS

1. Freudenheim JL Marshall JR, Vena JE, Moyslch KB, Mufi P, Loughlin R, Nemoto T, Graham S. Lactation history ond breast cancer risk. Am J Epidemiol 1997; 146{ 11): 932- 8. 2. Plessen V, Kolditz M, Bladtke L, Vogelsang F, Moysich K. Schafer H, Smit H, Basse H, Zickgraf T. Pichlmoyr R, Ketzler K, Gubernatis G. Total quality management including a detailed documentation system increases organ donation rotes by transparency of information and consecutive motivation. Transplant Proc 1997;29( 1-2): 1496-7. 3. Mendola P. Moysich KB, Freudenheim JL, Shields PG. Schistermon EF, Graham S, Veno JE. Morsholl JR. Ambrosone CB. Risk of recurrent spontaneous abortion, cigarette smoking, and genetic polymorphisms in NAT2 and GSTMl. Epidemiology 1998;9(6): 666-8.

17 NYSDEC OHMS Document No. 201469232-00113 4. Moysich KB, Ambrosone CB, Vena JE, Shields PG, Mendola P, Kostyniak P, Greizerstein H, Graham S, Marshall JR, Schisterman EF. Freudenheim JL. Environmental organochlorine exposure and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7(3}: 181-8. 5. Freudenheim JL. Ambrosone CB, Moysich KB, Vena JE, Graham S, Marshall JR, Muti P, Loughlin R, Nemoto T. Harty LC, Crits GA, Chon AW, Shields PG. Alcohol dehydrogenose 3 genotype modification of the association of alcohol consumption with breast cancer risk. Cancer Causes Control 1999;10(5): 369-77. 6. Moysich KB, Mendola P, Schisterman EF, Freudenheim JL Ambrosone CB, Vena JE. Shields PG, Kostyniak P, Greizerstein H, Graham S, Marshall JR. An evaluation of proposed frameworks for grouping polychlorinated biphenyl {PCB} congener data into meaningful analytic units. Am J Ind Med 1999;35(3): 223-31. 7. Moysich KB, Shields PG. Freudenheim JL. Schistermon EF. Vena JE, Kostyniak P, Greizerstein H, Marshall JR. Graham S. Ambrosone CB. Polychlarinated biphenyls. cytochrome P4501A1 polymorphism. and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev l 999;B( l ) : 41-4. 8. Moysich KB, Freudenheim JL Baker JA. Ambrosone CB, Bowman ED, Schisterman EF. Vena JE, Shields PG. Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk. Mal Carcinog 2000;27 ( 1) : 2-9. 9. Laden F, Collman G. Iwamoto K, Alberg AJ, Berkowitz GS, Freudenheim JL, Hankinson SE, Helzlsouer KJ, Holford TR, Huang HY, Moysich KB, Tessari JD, Wolff MS, Zheng T, Hunter DJ. 1. l-Dichloro-2.2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five U.S. studies. J Natl Cancer Inst 2001 ;9311 O}: 768-7 6. 10. Mccann SE, Moysich KB, Mettlin C. Intakes of selected nutrients and food groups and risk of ovarian cancer. Nutr Cancer 2001;39(1): 19-28. 11. Moysich KB, Mettlin C, Piver MS, Natarajan N, Menezes RJ, Swede H. Regular use of analgesic drugs and ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10(8): 903-6. 12. Noshchenko AG. Moysich KB. Bondar A. Zamostyan PV, Drosdova VD, Michalek AM. Patterns of acute leukaemia occurrence among children in the Chernobyl region. Int J Epidemiol 2001 ;30{ 1) : 125-9. 13. Swede H, Moysich KB, Freudenheim JL, Quirk JT, Muti PC, Hurd TC, Edge SB, Winston JS, Michalek AM. Breast cancer risk factors and HER2 over-expression in tumors. Cancer Detect Prev 2001 ;25(6): 511-9. 14. Bonner MR, Mccann SE. Moysich KB. Dietary factors and the risk of testicular cancer. Nutr Cancer 2002;44( 1): 35-43. 15. Mccann SE, Moysich KB, Freudenheim JL Ambrosone CB. Shields PG. The risk of breast cancer associated with dietary lignans differs by CYP 17 genotype in women. J Nu tr 2002; 132{ l O}: 3036-41. 16. Menezes RJ, Huber KR, Mahoney MC, Moysich KB. Regular use of aspirin and pancreatic cancer risk. BMC Public Health 2002;2: 18. 17. Moysich KB, Ambrosone CB, Mendola P, Kostyniok PJ, Greizerstein HB, Vena JE, Menezes RJ, Swede H, Shields PG, Freudenheim JL. Exposures associated with serum organochlorine levels among postmenopausal women from western New York State. Am J Ind Med 2002;41(2):102-10. 18. Moysich KB, Menezes RJ, Baker JA Falkner KL. Environmental exposure to polychlorinated biphenyls and breast cancer risk. Rev Environ Health 2002; 17(4}: 263- 77. 19. Movsich KB, Menezes RJ, Michalek AM. Chernobyl-related ionising radiation exposure and cancer risk: on epidemiological review. Lancet Oncol 2002;3(5): 269-79.

18 NYSDEC OHMS Document No. 201469232-00113 20. Moysich KB, Menezes RJ, Ronsani A. Swede H, Reid ME, Cummings KM, Falkner KL Loewen GM, Bepler G. Regular aspirin use and lung cancer risk. BMC Cancer 2002;2: 31. 21. Odunsi K, Ghamande S, Chandrasekaron EV, To A. Moysich KB. Driscoll D, Motto K, Lele S. Evaluation of betol ,4-galactosyltransferase as a potential biomarker far the detec tion of subclinicol disease ofter the completion of primary therapy for ovarian cancer. Am J Obstet Gynecol 2002;187(3): 575-80. 22. S(;histermon EF, Gollagher AM, Boirey Merz CN, Whitcomb BW, Faroggi D, Moysich KB, Lewin H. The association of hormone replacement therapy and coronary calcium as determined by electron beam tomography. J Womens Health Gend Based Med 2002:11 (7): 631-8. 23. Thrasher JF. Cummings KM. Michalek AM. Mahoney MC, Moysich KB. Pillittere DM. Colarectol cancer screening among ind ividuals with and without a family history. J Public Health Manog Pract 2002;8{2}: 1-9. 24. Zamostian P, Moysich KB. Mahaney MC, McCarthy P, Bandar A. Noschenko AG. Michalek AM. Influence of various factors on individual radiation exposure from the Chernobyl disaster. Environ Health 2002; l ( l): 4. 25. Ambrosone CB, Moysich KB, Furberg H, Freudenheim JL Bowman ED, Ahmed S, Graham S, Vena JE, Shields PG. CYPl 7 genetic polymorphism, breast cancer. and breast cancer risk factors. Breast Cancer Res 2003;5(2): R45-51. 26. Schisterman EF. Moysich KB. England LJ, Rao M. Estimation of the corre lation coefficient using the Bayesian Approach and its applications for epidemialogic research. BMC Med Res Methodol 2003;3: 5. 27. Swede H. Moysich KB, Winston JS, Hurd TC, Edge SB. Romero-Gutierrez M, Brooks JS. Michalek AM. Variation of the prognostic significance of HER-2 expression in breast cancer according ta tumor size. Breast J 2003;9{2): 98-105. 28. Freudenheim JL Bonner M, Krishnan S. Ambrosone CB. Graham S, Mccann SE, Moysich KB, Bowman E. Nemoto T, Shields PG. Diet and alcohol consumption in relation to p53 mutations in breast tumors. Carcinogenesis 2004;25(6): 931-9. 29. Joseph MA, Moysich KB, Freudenheim JL Shields PG, Bowman ED, Zhang Y, Marshall JR, Ambrosone CB. Cruciferous vegetables, genetic polymorphisms in glutothione S­ tronsferases M 1 and Tl. and prostate cancer risk. Nutr Cancer 2004;50(2): 206-13. 30. Mahoney MC, Lawvere S, Falkner KL Averkin YI, Ostapenko VA. Michalek AM, Moysich KB, McCarthy PL. Thyroid cancer incidence trends in Belarus: examining the impact of Chernobyl. Int J Epidemiol 2004;33{5): 1025-33. 31. Mahoney MC, Moyslch KB, McCarthy PL Jr., McDonald RC, Stepanenka VF, Day RW. Mic halek AM. The Chernobyl childhood leukemia study: background & lessons learned. Environ Health 2004;3( 1): 12. 32. Quirk JT, Natarajan N, Mettlin CJ. Moysich KB. Swede H. Risk Factors for Invasive Epithelial Ovarion Cancer by Histalogic Subtype. Online J Health Allied Scs 2004:3(2). 33. Yang J, Ton D, Asch HL Swede H, Bepler G, Gerodts J, Moysich KB . Prognostic significance of gelsolin expression level and variability in non-small cell lung cancer. Lung Cancer 2004;46( 1) : 29-42. 34. Boker JA, Buck GM, Vena JE. Moysich KB . Fertility patterns prior ta testicular cancer diagnosis. Cancer Causes Control 2005;16(3}: 295-9. 35. Baker JA, McCann SE, Reid ME, Nowell S, Beehler GP, Moysich KB . Associations between black tea and coffee consumption and risk of lung cancer among current and former smokers. Nutr Cancer 2005;52{ 1) :1 5-21. 36. Baker JA, Weiss JR, Czuczmon MS, Menezes RJ. Ambrosone CB, Moysich KB. Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma. Cancer Causes Control 2005;16(3}: 301-8.

19 NYSDEC OHMS Document No. 201469232-00113 37. Bloom MS, Vena JE, Swanson MK, Moysich KB, Olson JR. Profiles of ortho­ polychlorinated biphenyl congeners, dichlorodiphenyldichloroethylene, hexachlorobenzene, and Mirex among male Lake Ontario sportfish consumers: the New York State Angler cohort study. Environ Res 2005;97(2): 178-94. 38. Hahn T, Benekli M, Wong C, Moysich KB, Hyland A. Michalek AM, Alam A, Baer MR, Bambach B, Czuczman MS, Wetzler M, Becker JL McCarthy PL. A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease. Bone Marrow Transplant 2005;35(6): 557-66. 39. Mccann SE, Ambrosone CB, Moysich KB. Brasure J, Marshall JR, Freudenheim JL. Wilkinson GS, Graham S. Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nu tr Cancer 2005;53{ l ) : 33-41 . 40. Moysich KB, Boker JA. Rodabaugh KJ, Villella JA. Regular analgesic use and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2005; 14( 12): 2923-8. 41. wede H, Mirand AL Menezes RJ, Moysich KB. Association of regular aspirin use and breast cancer risk. Oncology 2005;68( l): 40-7. 42. Varma G, Varma R, Huang H, Pryshchepava A. Groth J, Fleming D, Nowak NJ, McQuaid D, Conroy J, Mahoney M, Moysich K, Falkner KL. Geradts J. Array comparative genomic hybridisation (aCGH} analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York. Br J Cancer 2005;93(6): 699-708. 43. Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14 Ill: 20-6. 44. Baker JA, Beehler GP, Sawant AC, Jayaprakash V, Mccann SE, Moysich KB. Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. J Nutr 2006; 136( l J: 166-71. 45. Baker JA. Odunuga 00, Rodabaugh KJ, Reid ME, Menezes RJ, Moysich KB. Active and passive smoking and risk of ovarian cancer. Int J Gynecol Cancer 2006; 16 Suppl l: 211-8. 46. Beehler GP, Sekhon M, Baker JA. Teter BE, Mccann SE, Rodabaugh KJ, Moysich KB. Risk of ovarian cancer associated with BMI varies by menopausal status. J Nutr 2006;136(11): 2881-6. 47. Bloom M, Vena J, Olson J, Moysich K. Chronic exposure to dioxin-like compounds and thyroid function among New York anglers. Environ Toxicol Pharmacol 2006;21(3):260-7. 48. Davis S, Day RW, Kopecky KJ, Mahoney MC, McCarthy PL. Michalek AM, Moysich KB, Onstad LE, Stepanenko VF, Voilleque PG, Chegerava T, Falkner K, Kulikov S, Maslova E, Ostapenko V, Rivkind N. Shevchuk V, Tsyb AF. Childhood leukaemia in Belarus, Russia, and Ukraine following the Chernobyl power station accident: results from an international collaborative population-based case-control study. Int J Epidemiol 2006;35{2}: 386-96. 49. Jayaprakash V, Menezes RJ, Javle MM, McCann SE, Baker JA, Reid ME, Natarajan N, Moysich KB. Regular aspirin use and esophageal cancer risk. Int J Cancer 2006: 119( l J: 202-7. 50. Jayaprakash V. Rigual NR, Moysich KB, Loree TR, Nasca MA, Menezes RJ, Reid ME. Chemoprevention of head and neck cancer with aspirin: a case-control study. Arch Otolaryngol Head Neck Surg 2006; 132( 11}: 1231-6. 51 . Li Y, Moysich KB, Baer MR. Weiss JR, Brasure J. Graham S. McCann SE. Intakes of selected food groups and beverages and adult acute myeloid leukemia. Leuk Res 2006;30(12): 1507-15. 52. Menezes RJ, Swede H, Niles R, Moysich KB. Regular use of aspirin and prostate cancer risk (United States}. Cancer Causes Control 2006; 17!3): 251-6.

20 NYSDEC OHMS Document No. 201469232-00113 53. Tennis M, Krishnan S, Bonner M, Ambrosone CB, Vena JE, Moysich K. Swede H, Mccann S, Hall P, Shields PG, Freudenheim JL. p53 Mutation analysis in breast tumors by a DNA microarroy method. Cancer Epidemiol Biomorkers Prev 2006;15(1):80-5. 54. Weiss JR, Baker JA, Boer MR, Menezes RJ, Nowell S. Moysich KB. Opposing effects of aspirin and ocetaminaphen use on risk of adult acute leukemia. Leuk Res 2006;30{2): 164-9. 55. Weiss JR, Kopecky KJ. Godwin J, Anderson J, Willman CL Moysich KB, Slovak ML Hoque A, Ambrosone CB. Glutathione S-transferose (GSTM 1, GSTTl ond GST A 1) polymorphisms and outcomes after treatment for acute myeloid leukemia: pharmocogenetics in Southwest Oncology Group {SWOG} clinical trials. Leukemia 2006;20{12): 2169-71. 56. Xie B, Freudenheim JL, Cummings SS, Singh B, He H, Mccann SE, Moysich KB. Shields PG. Accurate genotyping from paraffin-embedded normal tissue odjocent to breast cancer. Carcinogenesis 2006:27(2): 307-10. 57. Yang J, Ramnath N, Moysich KB, Asch HL, Swede H, Alrowi SJ, Huberman J, Geradts J, Brooks JS, Tan D. Prognostic significance of MCM2, Ki-67 and gelsolin in non-smoll cell lung cancer. BMC Cancer 2006;6: 203. 58. Boker JA, Boakye K, McCann SE, Beehler GP, Rodabaugh KJ, Villella JA. Moysich KB. Consumption of black teo or coffee and risk of ovarian cancer. Int J Gynecol Cancer 2007; l 7( l): 50-4. 59. Brody JG, Moysich KB. Humblet O. Attfield KR, Beehler GP, Rudel RA. Environmental pollutants and breast cancer: epidemiologic studies. Cancer 2007;109(12 Suppl): 2667- 711. 60. Brody JG, Rudel RA. Michels KB, Movsich KB. Bernstein L, Attfield KR, Gray S. Environmental pollutants. diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention? Cancer 2007;109(12 Suppl): 2627-34. 61. Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L, Tyrer J, Shadfarth D. Hogdall E, Hogdall C, Blaeker J, DiCioccio R, McGuire V, Webb PM, Beesley J, Green AC, Whiteman DC, Goodman MT, Lurie G, Corney ME, Modugno F. Ness RB, Edwards RP, Moysich KB, Goode EL Couch FJ. Cunningham JM, Sellers TA, Wu AH, Pike MC, Iversen ES, Marks JR, Garcio-Closos M, Brinton L Lissowska J, Peplonska B, Easton DF, Jacobs L Ponder BA. Schildkraut J, Pearce CL, Chenevix-Trench G, Berchuck A, Pharaoh PD. Tegging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2007;67(7): 3027-35. 62. Michels KB, Mohllajee AP, Roset-Bahmanyar E, Beehler GP, Moysich KB. Diet and breast cancer: a review of the prospective observational studies. Cancer 2007; 109{ 12 Suppl}: 2712-49. 63. Moysich KB, Baker JA, Menezes RJ, Jayoprakash V, Radabaugh KJ, Odunsi K, Beehler GP, Mccann SE. Villella JA. Usual adult body mass index is not predictive of ovarian cancer survival. Cancer Epidemiol Biomarkers Prev 2007; 16(3}: 626-8. 64. Moysich KB, Bonner MR, Beehler GP, Marshall JR, Menezes RJ, Boker JA, Weiss JR, Chanan-Khan A. Regular analgesic use and risk of multiple myeloma. Leuk Res 2007;31 (4): 547-51. 65. Weiss JR, Baer MR, Ambrosone CB, Blanco JG. Hutson A, Ford LA. Moysich K.B. Concordance of pharmacogenetic polymorphisms in tumor and germ line DNA in adult patients with acute myeloid leukemia. Cancer Epidemial Biomorkers Prev 2007;16(5): 1038-4 l. 66. Beehler GP, Baker JA. Falkner K, Chegerova T, Pryshchepova A. Chegerov V, Zevon M, Bromet E, Havenaar J, Valdismarsdottir H, Moysich KB. A multilevel analysis of long­ term psychological distress among Belarusians affected by the Chernobyl disaster, Public Health 2008; 122{ l 1} : 1239-49.

21 NYSDEC OHMS Document No. 201469232-00113 67. Ghosh C, Baker JA, Moysich KB. Rivera R, Brasure JR, McCann SE. Dietary intakes of selected nutrients and food groups and risk of cervical cancer. Nutr Cancer 2008;60( 3}: 331-4 l . 68. Heavey EJ, Moysich KB. Hyland A, Druschel CM, Sill MW. Female adolescents' perceptions of male partners' pregnancy desire. J Midwifery Womens Health 2008;53(4): 338-44. 69. Heavey EJ. Moysich KB. Hyland A, Druschel CM, Sill MW. Differences in pregnancy desire among pregnant female adolescents at a state-funded family planning clinic. J Midwifery Womens Health 2008;53(2}: 130-7. 70. Heavey EJ, Moysich KB, Hyland A, Druschel CM, Sill MW. Differences in contraceptive choice among female adolescents at a state-funded family planning clinic. J Midwifery Womens Health 2008;53(1 ): 45-52. 71. ayaprakash V, Natarajan KK, Moysich KB, Rigual NR. Ramnath N. Natarajan N. Reid ME. Wood dust exposure and the risk of upper aero-digestive and respiratory cancers in males. Occup Environ Med 2008;65(10): 647-54. 72. Menezes RJ, Cheney RT. Husain A, Tretiakova M. Loewen G, Johnson CS, Jayaprakash V, Moysich KB. Salgia R, Reid ME. Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue. Cancer Epidemiol Biomarkers Prev 2008;17(5): 1104-10. 73. Moyslch KB. Beehler GP, Zirpoli G. Choi JY. Baker JA. Use of common medications and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2008; 17 (7): 1564-9 5. 74. Ness RB, Shen C. Bass D. Jackson C, Moysich K. Edwards R. Brun ham RC. Chlamydia trachomatis serology in women with and without ovarian cancer. Infect Dis Obstet Gynecol 2008;2008: 219672. 75. Padmanabhan A, Boker JA. Zirpoli G. Sait SN, Ford LA. Moysich KB. Baer MR. Acute myeloid leukemia and myelodysplastic syndrome following breast cancer: increased frequency of other cancers and of cancers in multiple family members. Leuk Res 2008;32( 12): 1820-3. 76. Palmieri RT. Wilson MA, Iversen ES. Clyde MA. Colingoert B. Moorman PG, Poole C, Anderson AR, Anderson S, Anton-Culver H, Beesley J, Hogdoll E, Brewster W, Carney ME, Chen X, Chenevix-Trench G. Chang-Claude J, Cunningham JM, Dicioccio RA. Doherty JA, Easton DF. Edlund CK, Goyther SA. Gentry-Maharaj A, Goode EL, Goodmon MT, Kjaer SK, Hogdall CK. Hopkins MP, Jenison EL, Blaakaer J, Lurie G, McGuire V, Menon U. Moysich KB. Ness RB. Pearce CL, Pharoah PD. Pike MC, Ramus SJ, Rossing MA. Song H, Terada KY, Vandenberg D, Vierkant RA, Wang-Gohrke S, Webb PM. Whittemore AS, Wu AH, Ziogos A, Berchuck A. Schildkraut JM. Polymorphism in the 1Ll8 gene and epithelial ovarian cancer in non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 2008;17( 12): 3567-72. 77. Pearce CL Wu AH, Gayther SA, Bale AE. Beck PA, Beesley J, Chanock S, Cromer DW. DiCioccio R. Edwards R, Fredericksen ZS. Gorcio-Closas M, Goode EL, Green AC, Hartmann LC, Hogdall E, Kjaer SK. Lissowska J, McGuire V, Modugno F, Moysich K, Ness RB, Ramus SJ, Risch HA, Sellers TA. Song H, Strom DO, Terry KL Webb PM, Whiteman DC. Whittemore AS, Zheng W, Phoroah PD, Chenevix-Trench G. Pike MC, Schildkraut J. Berchuck A. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. Br J Cancer 2008;98(2): 282-8. 78. Peppone LJ, Mahoney MC, Cummings KM, Michalek AM, Reid ME, Moysich KB, Hyland A. Colorectol cancer occurs earlier in those exposed to tobacco smoke: implications for screening. J Cancer Res Clin Oncol 2008:134(7): 743-51. 79. Ramus SJ, Vierkant RA. Johnatty SE, Pike MC, Yon Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA. Dicioccio RA. McGuire Y, Whittemore AS, Song H. Easton OF, Pharoah PO, Gorcia-Closas M, Chanock S, Lissowsko J, Brinton L, 22 NYSDEC OHMS Document No. 201469232-00113 Terry KL, Cramer DW, Tworoger SS, Hankinson SE, Berchuck A. Moorman PG, Schildkraut JM, Cunningham JM, Liebow M, Kjoer SK, Hogdall E, Hogdall C, Blaakaer J, Ness RB, Moysich KB, Edwards RP, Corney ME, Lurie G, Goodman MT, Wang-Gahrke S, Kropp S, Chang-Claude J, Webb PM, Chen X. Beesley J, Chenevix-Trench G, Goode EL. Consortium analysis of 7 candidate SNPs for ovarian cancer. Int J Cancer 2008; 123(2): 380-8. 80. Tang L Zirpoli GR, Guru K, Moysich KB, Zhong Y, Ambrosone CB, Mccann SE. Consumption of raw cruciferous vegetables is inversely associated with bladder cancer risk. Cancer Epidemial Biomarkers Prev 2008:17(4): 938-44. 81. Jayaprakash V, Sullivan M. Merzianu M. Rigual NR, Laree TR, Popat SR, Moysich KB, Ramanonda S. Johnson T, Marshall JR, Hutson AD. Mang TS, Wilson BC. Gill SR, Frustino J, Bagaards A. Reid ME. Autofluorescence-guided surveillance for oral cancer. Cancer Prev Res {Philo) 2009:2(11):966-7 4. 82. Jahnatty SE, Beesley J, Chen X, Spurdle AB, Defazio A. Webb PM, Goade EL, Rider DN. Vierkant RA. Anderson S, Wu AH, Pike M, Van Den Berg D. Moysich K, Ness R, Doherty J, Rossing MA. Pearce CL Chenevix-Trench G. Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium. Twin Res Hum Genet 2009;12(3): 269-75. 83. Mccann SE, Yeh M, Rodabaugh K, Moysich KB. Higher regular coffee and tea consumption is associated with reduced endometrial cancer risk. Int J Cancer 2009;124(7}: 1650-3. 84. Pearce CL Near AM. Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A. Menon U, Goyther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, Doherty JA, Rossing MA, Whittemore AS, McGuire V, DiCiaccia RA, Goodman MT. Lurie G, Carney ME, Wilkens LR, Ness RB. Moysich KB, Edwards R, Jennison E, Kjaer SK. Hogdall E, Hogdall CK, Goode EL, Sellers TA. Vierkont RA. Cunningham JM. Schildkraut JM, Berchuck A, Moorman PG, Iversen ES, Cramer DW, Terry KL. Vitanis AF. Titus-Ernstoff L. Song H, Pharaoh PD. Spurdle AB, Anton-Culver H, Ziagas A, Brewster W, Galitovskiy V. Chenevix-Trench G. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer 2009; l 00(2): 412-20. 85. Peppone LJ, Hyland A, Moysich KB. Reid ME, Piazza KM. Purnell JQ, Mustian KM, Morrow GR. Examining the association between cigarette smoking and colorectal cancer using historical case-control data. Cancer Epidemiol 2009;33(3-4): 182-8. 86. Qian F, Villella J. Wallace PK, Mhawech-Fauceglia P, Taria JD. Jr .• Andrews C, Matsuzaki J, Valmori D, Ayyoub M, Frederick PJ, Beck A, Liao J, Cheney R. Moysich K, Lele S, Shrikant P, Old LJ, Odunsi K. Efficacy of levo-1-methyl tryptaphan and dextro-1- methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer. Cancer Res 2009:69(13): 5498-504. 87. Quaye L Sang H, Ramus SJ, Gentry-Maharaj A, Hogdall E, DiCioccio RA, McGuire V, Wu AH. Van Den Berg DJ, Pike MC, Wozniak E. Doherty JA. Rossing MA. Ness RB. Moysich KB. Hogdall C. Blaakaer J, Easton DF. Ponder BA. Jacobs IJ. Menon U, Whittemore AS, Kruger-Kjaer S, Pearce CL Pharoah PD. Gayther SA. Tagging single­ nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. Br J Cancer 2009;10016): 993-1001. 88. Song H, Ramus SJ. Kjoer SK, DiCiaccia RA. Chenevix-Trench G, Pearce CL, Hagdall E, Whittemore AS, McGuire V, Hogdall C, Blaakaer J, Wu AH. Van Den Berg DJ. Stram DO, Menon U. Gentry-Maharaj A, Jacobs IJ, Webb PM, Beesley J, Chen X. Rossing MA. Doherty JA, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Ness RB, Moysich K, Goode EL Vierkant RA. Cunningham JM, Anderson S, Schildkraut JM, Berchuck A. Iversen ES. Moorman PG, Garcia-Closas M, Chanock S, Lissowska J, Brinton L Anton-Culver H, Ziogas A, Brewster WR, Ponder BA, Easton DF.

23 NYSDEC OHMS Document No. 201469232-00113 Gayther SA. Pharoah PD. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum Mol Genet 2009;18( 12): 2297-304. 89. Song H, Ramus SJ, Tyrer J, Bolton KL Gentry-Maharaj A. Wozniak E. Anton-Culver H, Chong-Claude J. Cromer DW, DiCioccio R, Dork T. Goode EL Goodman MT, Schildkraut JM, Sellers T. Baglietto L Beckmann MW, Beesley J, Blaakaer J, Carney ME, Chanock S. Chen Z. Cunningham JM, Dicks E. Doherty JA Durst M, Ekici AB, Fenstermacher D, Fridley BL. Giles G, Gore ME, De Vivo I. Hillemanns P. Hogdall C, Hogdoll E, Iversen ES, Jacobs IJ. Jakubowsko A, Li 0, Lissowska J, Lubinski J, Lurie G, McGuire V, Mclaughlin J, Medrek K, Moorman PG, Movsich K, Narod S, Phelan C, Pye C, Risch H, Runnebaum IB, Severi G. Southey M, Stram DO, Thiel FC, Terry KL, Tsai YY, Tworager SS. Van Den Berg DJ, Vierkant RA. Wang-Gohrke S, Webb PM. Wilkens LR, Wu AH, Yong H, Brewster W, Ziogos A. Houlston R, Tomlinson I, Whittemore AS. Rossing MA. Ponder BA, Pearce CL. Ness RB. Menon U, Kjoer SK. • Gronwold J, Garcia-Closas M. Fasching PA. Easton OF, Chenevix-Trench G, Berchuck A. Pharaoh PD, Goyther SA. A genome-wide association study identifies a new ovarian cancer susceptibility locus an 9p22.2. Nat Genet 2009;41 (9): 996-1000. 90. Yeh M, Moysich KB, Jayaprakash V, Rodabaugh KJ, Grahams. Brasure JR. McCann SE. Higher intakes of vegetables and vegetable-related nutrients are associated with lower endometrial cancer risks. J Nutr 2009:139{2): 317-22. 91. Bolton KL TJ, Song H. Ramus SJ. Notaridou M. Jones C, Sher T, Gentry-Maharaj A Wozniak E. Tsai YY, Weidhaas J, Paik D, Van Den Berg OJ, Stram 00, Pearce CL, Wu AH, Brewster W. Anton-Culver H, Ziogas A, Narod SA, Levine DA. Kaye SB, Brown R, Poul J, Flanagan J. Sieh W, McGuire V, Whittemore AS, Campbell I, Gore ME, Lissowska J, Yang HP, Medrek K, Granwald J, Lubinski J, Jakubowska A,Le ND, Cook LS. Kelemen LE, Brook-Wilson A, Massuger LF, Kiemeney LA, Aben KK,van Altena AM, Haulston R, Tomlinson I. Palmieri RT. Moorman PG, Schildkraut J,lversen ES, Phelan C, Vierkant RA. Cunningham JM, Goode EL. Fridley BLKruger-Kjoer S. Blaeker J. Hogdall E, Hogdall C. Grass J. Karlan BY, Ness RB.Edwards RP. Odunsi K. Moysich KB, Baker JA, Modugno F. Heikkinenen T, Butzow R,Nevanlinna H, Leminen A. Bogdanova N. Antonenkova N. Doerk T, Hillemonns P. Durst M, Runnebaum I, Thompson PJ ,Carney ME, Goodman MT, Lurie G, Wang-Gehrke S, Hein R, Chang-Claude J, Rossing MA, Cushing-Haugen KL Doherty J, Chen C, Rafnar T. Besenbocher S, Sulem P,Stefonsson K. Birrer MJ, Terry KL Hernandez 0, Cramer OW, Vergote I. Amant F, Lambrechts D. Despierre E, Fasching PA. Beckmann MW, Thiel FC. Ekici AB, Chen X; Australian Ovarian Cancer Study Group: Australian Cancer Study (Ovarian Cancer): Ovarian Concer Association Consortium, Johnatty SE, Webb PM, Beesley J. Chanock S, Garcio-Closas M, Sellers T, Easton DF,Berchuck A. Chenevix-Trench G, Pharoah PD. Goyther SA. Common variants at 19p 13 are associated with susceptibility to ovarian cancer. Nat Genet 2010;42110): 880-4. 92. Brosky TM, Bonner MR. Moysich KB. Ambrosone CB, Nie J, Toa MH, Edge SB, Kallakury BV, Marian C, Trevisan M. Shields PG, Freudenheim JL. Non-steroidal anti-inflammatory drug (NSAIO) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes Control 2010;21 (9): 1503-l 2. 93. Doherty JA. Rossing MA. Cushing-Haugen KL, Chen C, Van Den Berg OJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chong-Claude J, Wong-Gehrke S, Goodman MT, Lurie G. Thompson PJ, Carney ME. Hagdall E. Kjaer SK, Hagdall C, Goode EL Cunningham JM, Fridley BL, Vierkant RA, Berchuck A. Moorman PG, Schildkraut JM, Palmieri RT, Cromer OW. Terry KL, Yang HP, Garcia-Closas M, Chanock S, Lissowska J, Sang H. Pharaoh PO, Shah M, Perkins B, McGuire V. Whittemore AS, Di Ciaccio RA, Gentry-Maharaj A, Menon U, Gayther SA, Ramus SJ, Ziogas A, Brewster W, Anton-Culver H. Pearce CL. ESRl/SYNEl polymorphism and 24 NYSDEC OHMS Document No. 201469232-00113 invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomarkers Prev 2010;19(1):245-50. 94. Goode EL. Chenevix-Trench G, Song H, Ramus SJ. Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC. Kjaer SK, Birrer MJ, Berchuck A, Schildkrout J, Tomlinson I, Kiemeney LA, Cook LS, Gronwold J, Gorcio-Closas M, Gare ME, Campbell L Whittemore AS, Sutphen R, Phelan C, Anton-Culver H. Pearce CL, Lambrechts D. Rossing MA. Chang-Claude J, Moysich KB, Goodman MT. Dork T, Nevanlinna H. Ness RB. Rafnar T, Hogdall C, Hogdall E. Fridley BL. Cunningham JM, Sieh W, McGuire V, Godwin AK, Cramer OW, Hernandez D. Levine D. Lu K. Iversen ES, Palmieri RT. Houlston R, van Altena AM. Aben KK, Massuger LF. Brooks-Wilson A, Kelemen LE, Le ND, Jakubowska A, Lubinski J, Medrek K, Stafford A, Easton DF, Tyrer J, Bolton KL. Harrington P, Eccles D. Chen A, Molina AN, Davila SN, Arango H, Tsai YY, Chen Z, Risch HA, Mclaughlin J, Narod SA. Ziogos A, Brewster W, Gentry-Maharaj A, Menan U, Wu AH. Stram DO, Pike MC, Beesley J, Webb PM, Chen X, Ekici AB, Thiel FC, Beckmann MW. Yang H, Wentzensen N, Lissowska J, Fasching PA, Despierre E. Amant F, Vergote I, Doherty J, Hein R, Wang-Gohrke S, Lurie G. Carney ME, Thompson PJ. Runnebaum I, Hillemanns P, Durst M, Antonenkova N. Bogdanova N, Leminen A, Butzow R, Heikkinen T. Stefanssan K, Sulem P. Besenbacher S, Sellers TA, Gayther SA. Pharaoh PD. A genome-wide association study identifies susceptibility loci for ovarian cancer a t 2q3l and 8q24. Nat Genet 2010;42(10): 874-9. 95. Hampros SS, Sucheston L Weiss J, Baer MR, Zirpoli G. Singh PK. Wetzler M. Chennamaneni R, Blanco JG, Ford L. Moysich KB. Genetic polymorphisms of ATP­ binding cassette (ABC) proteins, overall survival and drug toxicity in patients with Acute Myeloid Leukemia. Int J Mol Epidemiol Genet 2010;1 (3): 201-7. 96. Johnatty SE, Beesley J. Chen X. Macgregor S, Duffy DL Spurdle AB. deFazio A, Gava N, Webb PM. Rossing MA. Doherty JA. Goodman MT, Lurie G. Thompson PJ, WHkens LR, Ness RB. Moysich KB, Chong-Claude J. Wang-Gehrke S, Cramer DW, Terry KL Hankinson SE, Tworoger SS, Garcio-Closas M. Yang H, Lissowska J, Chanack SJ, Pharaoh PD. Song H, Whitemore AS, Pearce CL Stram DO, Wu AH, Pike MC, Goyther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Anton-Culver H. Ziogas A, Hogdall E, Kjaer SK, Hogdall C, Berchuck A. Schildkraut JM. Iversen ES, Moorman PG, Phelan CM, Sellers TA, Cunning ham JM, Vierkant RA, Rider DN, Goode EL, Haviv I, Chenevix-Trench G. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS Genet 2010;6(7): el001016. 97. Kele men LE, Goodman MT. McGuire Y, Rossing MA, Webb PM, Kobel M. Anton-Culver H. Beesley J, Berchuck A, Brar S, Carney ME. Chang-Claude J, Chenevix-Trench G, Cramer OW, Cunningham JM, Dicioccio RA. Do herty JA, Easton DF, Fredericksen ZS. Fridley BL. Gates MA. Gayther SA. Gentry-Maharaj A. Hogdall E, Kjaer SK, Lurie G, Menon U, Moorman PG, Moysich K, Ness RB. Pa lmieri RT , Pearce CL, Pharoah PD. Ramus SJ, Song H. Stram DO. Tworoger SS, Von Den Berg 0, Yierkant RA. Wang-Gohrke S, Whit1emore AS, Wilkens LR, Wu AH . Schildkraut JM, Sellers TA. Goade EL. Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 201O;19 (7): 1822-30. 98. Kuptsova-Clarkson N. Ambrosone CB. Weiss J, Baer MR, Sucheston LE, Zirpoli G. Kopecky KJ, Ford L. Blanco J. Wetzler M, Moyslch KB. XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myelaid leukemia. Int J Mol Epidemiol Genet 2010;1 (4): 278-94. 99. Peppane LJ. Reid ME, Moysich KB, Morrow GR, Jean-Pierre P, Mohile SG, Darling TV. Hyland A. The effect of secondhand smoke exposure on the association between 25 NYSDEC OHMS Document No. 201469232-00113 active cigarette smoking and colarectal cancer. Cancer Causes Control 2010;21 (8): 1247-55. l 00. Phelan CM. Tsai YY, Goode EL, Vierkant RA. Fridley BL, Beesley J, Chen XQ, Webb PM, Chanock S, Cramer DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M. Yang H, Wang-Gohrke S, Hein R, Green AC. Lissowska J, Carney ME, Lurie G, Wilkens LR. Ness RB, Pearce CL Wu AH, Van Den Berg DJ, Stram DO, Terry KL Whiteman DC, Whittemore AS, DiCioccia RA. McGuire V, Doherty JA. Rossing MA. Antan-Culver H, Ziagas A, Hogdall C, Hagdall E. Kruger Kjaer S, Blaakaer J, Quaye L, Ramus SJ, Jacobs I, Song H, Pharoah PD, Iversen ES, Marks JR, Pike MC, Gayther SA. Cunningham JM, Goodman MT. Schildkraut JM, Chenevix-Trench G. Berchuck A. Sellers TA. Polymorphism in the GALNTl gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2010;19(2}: 600-4. 101. Tang L Zirpoli GR, Guru K, Moysich KB, Zhang Y, Ambrosone CB, McCann SE. Intake of cruciferous vegetables modifies bladder cancer survival. Cancer Epidemial Biamarkers Prev 2010;19(7): 1806-11. 102. Tang L Zirpoli GR. Jayaprakash V, Reid ME, Mccann SE. Nwogu CE. Zhong Y, Ambrosone CB, Moysich KB. Cruciferous vegetable intake is inversely associated with lung cancer risk among smokers: a case-control study. BMC Cancer 2010;10: 162. 103. Brosky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C. Goerlitz DS. Trevisan M. Shields PG, Freudenheim JL. Non-steroidal a.nti­ inflammatory drugs (NSAIDsJ and breast cancer risk: differences by molecular subtype. Cancer Causes Control 2011 ;22(7): 965-75. 104. Brosky TM, Banner MR. Moysich KB, Ochs-Balcom HM, Marian C, Ambrosone CB, Nie J, Tao MH, Edge SB. Trevisan M. Shields PG, Freudenheim JL. Genetic variants in COX-2, nan-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB} Study. Breast Cancer Res Treat 201l;l26(1}:157-65. l 05. Cox DG, Simard J, Sinnett D. Hamdi Y. Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L Healey S, Szabo C. Greene MH, Mai PL Andrulis IL. Thomassen M, Gerdes AM, Caligo MA. Friedman E, Laitman Y, Kaufman B, Paluch SS, Borg A. Karlsson P. Askmalm MS, Bustinza GB. Nathanson KL Domchek SM, Rebbeck TR, Benitez J. Hamann U, Raokus MA, van den Ouweland AM. Ausems MG. Aalfs CM, van Asperen CJ, Devilee P, Gille HJ, Peock S, Frost D, Evans DG. Eeles R, Izatt L Adlard J, Paterson J, Eason J, Godwin AK, Remon MA. Moncautier V, Gauthier-Villars M, Lasset C, Giraud S. Hardouin A. Berthet P. Sobol H. Eisinger F, Bressac de Poillerets B, Caron O. Delnatte C, Goldgor D, Miron A, Ozcelik H, Buys S, Southey MC, Terry MB. Singer CF, Dressler AC, Tea MK, Hansen TV. Johannsson 0, Piedmonte M, Rodriguez GC, Basil JB, Blank S. Toland AE, Montagna M, Isaacs C, Blanco I. Gayther SA, Moysich KB. Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Niederocher D. Sutter C, Gadzicki D, Fiebig B, Caldes T, Laframboise R, Nevanlinna H, Chen X, Beesley J, Spurdle AB, Neuhousen SL. Ding YC. Couch FJ, Wang X, Peterlonga P, Manoukian S, Bernard L, Radice P, Easton OF, Chenevix-Trench G, Antoniou AC, Stoppa-Lyonnet D. Mazoyer S, Sinilnikava OM. Common variants of the BRCA 1 wild-type allele modify the risk of breast cancer in BRCA 1 mutation carriers. Hum Mol Genet 2011 ;20(23}: 4732-47. l 06. Huang RS, Johnatty SE, Gamazon ER, Im HK, Ziliak D, Duan S, Zhang W, Kistner EO, Chen P, Beesley J. Mi S, O'Donnell PH, Fraiman YS, Das S, Cox NJ, Lu Y. Macgregor S, Goode EL Vierkant RA. Fridley BL. Hogdall E. Kjaer SK, Jensen A. Moysich KB, Grasela M. Odunsi K, Brown R, Paul J, Lambrechts D, Despierre E, Vergote I, Gross J, Karlan BY, Defazio A. Chenevix-Trench G, Dolan ME. Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients. Clin Cancer Res 201l:17(16):5490-500.

26 NYSDEC OHMS Document No. 201469232-00113 107. Lurie G, Wilkens LR, Thompson PJ, Shvetsov YB, Matsuno RK, Corney ME, Palmieri RT. Wu AH. Pike MC, Pearce CL, Menon U, Gentry-Maharaj A. Gayfher SA. Ramus SJ, Whittemore AS, McGuire V, Sieh W, Phorooh PD, Song H, Gronwold J, Jokubowsko A, Cybulski C, Lubinski J. Schildkro uf JM. Berchuck A. Kruger Kjoer S, Hogdall E. Fasching PA. Beckmann MW, Ekici AB. Hein A. Chenevix-Trench G, Webb PM. Beesley J, Goodman MT. Estrogen receptor beta rsl271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium. PLoS One 2011;6(6): e20703. 108. Marimuthu SP, Vijayaragavan P, Moysich KB, Jayaprakash v. Diabetes mellitus and gastric carcinoma: Is there on a ssociation? J Carcinog 20 11; 1O: 30. 109. Moysich KB, McCarthy P, Holl P. 25 years ofter Chernobyl: lessons for Japan? Lancet Oncol 2011; 12(5): 416-8. 110. Mulligan AM. Couch FJ, Barrowdole D, Domchek SM. Eccles D, Nevonlinna H, Ramus SJ, Robson M, Sherman M, Spurdle AB, Wappenschmidt B, Lee A. McGuffog L. Healey S, Sinilnikovo OM, Janavicius R, Hansen T, Nielsen FC, Ejlertse n B. Osorio A, Munoz­ Repeto I, Duron M, Godino J, Pertesi M, Benitez J, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Bonanni B, Viel A. Pasini B. Popi L Ottini L, Savarese A, Bernard L Radice P, Hamann U, Verheus M. Meijers-Heijboer HE, Wijnen J, Gomez Garcia EB. Nelen MR, Kets CM. Seynoeve C, Tilanus-Linthorst MM, van der Luijt RB, van Os T, Rookus M. Frost D, Jones JL Evans DG, Lalloa F. Eeles R, Izatt L Adlard J, Davidson R. Cook J, Donaldson A. Dorkins H, Gregory H, Eason J. Houghton C. Barwell J, Side LE, McCann E. Murray A, Peock S, Godwin AK, Schmutzler RK, Rhiem K. Engel C, Meindl A. Ruehl I, Arnold N, Niederocher D, Sutter C, Deissler H. Godzicki D, Kast K, Preisler-Adams S, Varon-Mateeva R. Schoenbuchner I, Fiebig B, Heinritz W, Schafer D. Gevensleben H, Caux-Mancoutier V, Fassy-Colcombet M, Cornelis F, Mazoyer S, Leone M, Boutry-Kryza N, Hardouin A. Berthet P, Muller D. Fricker JP, Mortemousque I, Pujol P, Coupier t, Lebrun M, Kientz C, Longy M. Sevenet N, Stoppa-Lyonnet D, Isaacs C, Caldes T. de la Hoya M, Heikkinen T, Aittomaki K, Blanco I, Lazaro C, Borkardottir RB, Soucy P, Dumont M, Simard J, Montagna M, Tognazzo S, D'Andrea E, Fox S, Yan M, Rebbeck T, Olopade 0, Weitzel JN, Lynch HT, Ganz PA. Tomlinson GE. Wong X, Fredericksen Z, Pankratz VS. Lindor NM, Szobo C. Offit K, Sakr R. Gaudet M, Bhatia J, Kauff N, Singer CF, Tea MK, Gschwontler-Kaulich D. Fink-Retter A, Mai PL Greene MH, lmyanitov E, O'Malley FP, Ozcelik H, Glendon G, Toland AE, Gerdes AM. Thomassen M, Kruse TA, Jensen UB, Skytte AB. Caligo MA. Soller M, Henriksson K, Wachenfeldt v A. Arver B, Stenmark­ Askmalm M, Karlsson P, Ding YC . Neuhausen SL, Beattie M, Pharoah PD, Moysich KB, Nathanson KL. Karlon BY. Gross J. Jahn EM, Daly MB, Buys SM, Southey MC, Hopper JL Terry MB, Chung W, Miran AF, Goldgar D, Chenevix-Trench G, Easton DF, Andrulis IL, Antoniou AC. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA 1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCAl /2. Breast Cancer Res 2011 ;13(6): Rl 10. 111. f'lear AM, Wu AH, Templeman C, Von Den Berg DJ, Doherty JA, Rossing MA. Goode EL Cunningham JM, Vierkant RA, Fridley BL, Chenevix-Trench G. Webb PM, Kjaer SK, Hagdall E, Gayther SA. Ramus SJ, Meno n U. Gentry-Maharaj A, Schildkrout JM. Moorman PG, Palmieri RT. Ness RB. Moystch K, Cromer DW, Terry KL, Vitonis AF, Pike MC, Berchuck A. Pearce CL Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort. Fertil Steril 2011 ;95(1 ): 40-5. 112. Ness RB, Dodge RC, Edwards RP, Baker JA, Moysich KB. Contraception methods, beyond oral contraceptives and tubal ligotion, and risk of ovarian cancer. Ann Epidemiol 2011;21(3):188-96. 113. Notaridou M. Quaye L Dafou D, Jones C, Song H. Hogdall E, Kjaer SK, Christensen L Hogdoll C, Blaakaer J, McGuire v. Wu AH. Von Den Berg DJ, Pike MC, Gentry-Maharaj 27 NYSDEC OHMS Document No. 201469232-00113 A. Wozniak E. Sher T, Jacobs IJ, Tyrer J, Schildkraut JM. Moorman PG, Iversen ES. Jokubowsko A. Medrek K. Lubinski J, Ness RB, Moysich KB. Lurie G, Wilkens LR, Carney ME, Wang-Gohrke S. Doherty JA. Rossing MA. Beckmann MW, Thiel FC, Ekici AB, Chen X. Beesley J, Gronwald J, Fasching PA. Chang-Claude J, Goodman MT, Chenevix­ Trench G, Berchuck A. Pearce CL, Whittemore AS, Menon U. Pharooh PD. Gayther SA. Ramus SJ. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer 2011: 128(9): 2063-7 4. 114. Pearce CL, Doherty JA. Van Den Berg DJ, Moysich K. Hsu C, Cushing-Haugen KL. Conti DV, Ramus SJ, Gentry-Maharaj A. Menon U, Goyther SA. Phorooh PD, Song H, Kjaer SK. Hagdall E, Hogdall C, Whittemore AS. McGuire V, Sieh W, Gronwald J, Medrek K, Jakubowska A. Lubinski J. Chenevix-Trench G, Beesley J, Webb PM, Berchuck A, Schildkraut JM. Iversen ES. Moorman PG, Edlund CK, Stram DO. Pike MC, Ne·ss RB. Rossing MA, Wu AH. Genetic variation in insulin-like growth factor 2 may ploy a role in ovarian cancer risk. Hum Mol Genet 2011;20(11 ): 2263-72. 115. Pharoah PD, Palmieri RT. Ramus SJ, Gayther SA. Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS, Beckmann MW. Birrer MJ, Bogdanova N, Bolton KL, Brewster W, Brooks-Wilson A. Brown R, Butzow R, Caldes T, Coligo MA. Campbell I, Chang-Claude J, Chen YA. Cook LS. Couch FJ, Cramer DW. Cunningham JM, Despierre E, Doherty JA. Dork T, Durst M, Eccles OM, Ekici AB. Easton D, Fasching PA. de Fazio A. Fenstermacher DA. Flanagan JM, Fridley BL, Friedman E, Gao B. Sinilnikova 0, Gentry-Maharaj A, Godwin AK, Goode EL. Goodman MT. Grass J, Hansen TV, Harnett P, Rookus M, Heikkinen T. Hein R. Hogdall C. Hogdall E, Iversen ES, Jakubowska A. Johnatty SE, Karlan BY, Kauff ND. Kaye SB, Chenevix-Trench G, Kelemen LE, Kiemeney LA. Kjaer SK, Lambrechts D, Lapolla JP, Lazaro C, Le ND, Leminen A. Leunen K. Levine DA, Lu Y. Lundvall L Macgregor S, Marees T. Massuger LF, Mclaughlin JR. Menon U, Montagna M, Moysich KB, Narod SA, Nathanson KL, Nedergaard L. Ness RB. Nevanlinna H, Nickels S. Osorio A, Paul J, Pearce CL. Phelan CM. Pike MC, Radice P, Rossing MA, Schildkraut JM, Sellers TA. Singer CF, Song H, Strom DO, Sutphen R. Lindblom A. Terry KL, Tsai YY, van Altena AM. Vergate L Vierkant RA. Vitonis AF. Walsh C. Wang-Gehrke S, Wappenschmidt B, Wu AH, Ziogos A. Berchuck A, Risch HA. The role of KRAS rs6 l 764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res 2011 ; 17 { l 1) : 3742-50. 116. Ramus SJ, Kartsonaki C. Gayther SA. Pharaoh PD, Sinilnikova OM, Beesley J. Chen X, McGuffog L Healey S. Couch FJ, Wang X, Fredericksen Z, Peterlongo P. Manoukian S. Peissel B. Zaffaroni D, Roversi G, Barile M. Viel A, Allavena A. Ottini L. Papi L Gismondi V, Capra F, Radice P. Greene MH. Mai PL. Andrulis IL, Glendon G, Ozcelik H, Thomassen M, Gerdes AM, Kruse TA. Cruger D. Jensen UB. Coligo MA. Olsson H. Kristoffersson U, Lindblom A. Arver B. Karlsson P, Stenmark Askmalm M, Borg A. Neuhausen SL. Ding YC, Nathanson KL. Domchek SM. Jakubowska A. Lubinski J. Huzarski T. Byrski T, Gronwald J. Gorski B. Cybulski C, Debniok T, Osorio A, Duron M. Tejada ML Benitez J. Hamann U, Rookus MA, Verhoef S, Tilanus-Linthorst MA. Vreeswijk MP, Bodmer D, Ausems MG, van Os TA. Asperen CJ. Blok MJ. Meijers-Heijboer HE, Peock S, Cook M. Oliver C, Frost D. Dunning AM, Evans DG. Eeles R, Pichert G, Cole T, Hodgson S, Brewer C. Morrison PJ, Porteous M, Kennedy MJ, Rogers MT, Side LE, Donaldson A. Gregory H. Godwin A, Stoppa-Lyonnet D. Moncoutier V, Castera L. Mazayer S, Barjhoux L, Bonadona V, Leroux D, Faivre L. Lidereau R. Nogues C, Bignon YJ, Prieur F, Collonge-Rame MA. Venat-Bouvet L Fert-Ferrer S, Miran A, Buys SS, Hopper JL, Daly MB. John EM, Terry MB, Goldgor D, Hansen T, Jonson L, Ejlertsen B, Agnarsson BA. Offit K. Kirchhoff T, Vijai J. Dutra-Clarke AV, Przybylo JA, Montagna M, Casella C, lmyonitov EN. Jonovicius R, Blanco I, Lazaro C. Moysich KB, Karlan BY, Gross J, Beattie MS, Schmutzler R, Wappenschmidt B. Meind I A, Ruehl I, Fiebig B. Sutter C. Arnold N, Deissler H, Varon-Mateeva R, Kast K. Niederocher D, Gadzicki D, Caldes T, de la Hoya

28 NYSDEC OHMS Document No. 201469232-00113 M, Nevanlinna H. Aittamaki K. Simard J, Saucy P, Spurdle AB, Holland H, Chenevix­ Trench G, Easton DF, Antoniou AC. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA 1 and BRCA2 mutation carriers. J Natl Cancer Inst 2011;l03(2): l 05-16. 117. Beral V, Gaitskell K, Hermon C, Moser K, Reeves G, Peto R. Ovarian cancer and smoking: individual participant meta-analysis including 28, 114 women with ovarian cancer from 51 epidemiological studies. Lancet Oneal 2012;13(9}: 946-56. 118. Bolton KL, Chenevix-Trench G. Goh C, Sadetzki S. Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton DF. Sinilnikava 0, Benitez J, Garcia MJ, Neuhausen S, Gail MH, Hartge P, Peack S. Frost D, Evans DG, Eeles R, Godwin AK, Daly MB. Kwong A, Ma ES. Lazaro C. Blanca I, Montagna M, D'Andrea E. Nicolette MO, Johnatty SE, Kjaer SK, Jensen A, Hogdall E, Goode EL, Fridley BL, Loud JT, Greene MH, Mai PL, Chetrit A, Lubin F, Hirsh-Yechezkel G, Glendon G, Andrulis IL, Toland AE. Senter L, Gore ME. Gourley C, Michie CO, Song H, Tyrer J, Whittemore AS, McGuire V, Sieh W. Kristoffersson U, Olsson H, Borg A. Levine DA, Steele L, Beattie MS. Chan S, Nussbaum RL, Moysich KB, Gross J, Coss I. Walsh C, Li AJ, Leuchter R, Gordon 0, Garcia-Closas M, Gayther SA. Chanock SJ, Antoniou AC. Pharoah PD. Association between BRCA 1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA. 2012 Jan; 307(4}: 382-90. 119. Hampras SS, Nesline M, Wallace PK, Odunsi K, Furlani N, Davis W, Movsich KB. Predictors of immunosuppressive regulatory T lymphocytes in healthy women. J Cancer Epidemiol. 2012; 2012: 191090. 120. Kurta ML. Moysich KB, Weissfeld JL, Youk AO, Bunker CH, Edwards RP. Modugno F, Ness RB, Diergaarde B. Use of fertility drugs and risk of ovarian cancer: results from a U.S.­ based case-control study. Cancer Epidemiol Biomarkers Prev. 2012 Aug; 21 (8): 1282- 92. J 21. La-Ciganic WH, Zgibar JC, Bunker CH, Moysich KB, Edwards RP, Ness RB. Aspirin, nonaspirin nonsteraidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer. Epidemiology. 2012 Mar; 23(2): 311-9. 122. Mavaddat N, Barrowdale D, Andrulis IL, Damchek SM. Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L. Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O'Malley F, Jahn EM, Janavicius R, Tihomirova L Hansen TV, Nielsen FC. Osorio A, Stavropoulau A. Benitez J, Manoukian S. Peissel B. Barile M, Volorio S. Pasini B, Dolcetti R. Putignana AL, Ottini L, Radice P, Hamann U, Rashid MU, Hogervorst FB, Kriege M, van der Luijt RB, Peock S. Frost D, Evans DG. Brewer C, Walker L, Rogers MT, Side LE. Houghton C, Weaver J, Godwin AK, Schmutzler RK, Wappenschmidt B, Meindl A, Kast K, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D. Preisler-Adams S, Varon-Mateeva R. Schanbuchner L Gevensleben H, Stoppa-Lyonnet D. Belotti M. Barjhoux L, Isaacs C, Peshkin BN. Caldes T, de la Hoya M, Canadas C, Heikkinen T, Heikkila P, Aittomaki K, Blanco I, Lazaro C, Brunet J. Agnarsson BA. Arason A. Barkardottir RB, Dumont M. Simard J, Montagna M, Agata S, D'Andrea E, Yan M, Fox S, Rebbeck TR, Rubinstein W, Tung N, Garber JE, Wang X, Fredericksen Z, Pankratz VS. Lindar NM. Szabo C, Offit K, Sakr R, Gaudet MM, Singer CF. Tea MK. Rappaport C, Mai PL, Greene MH, Sokolenka A. lmyanitov E. Toland AE. Senter L Sweet K, Thomassen M, Gerdes AM. Kruse T, Caliga M, Aretini P, Rantala J, van Wachenfeld A. Henriksson K, Steele L, Neuhausen SL, Nussbaum R. Beattie M, Odunsi K, Sucheston L Gayther SA. Nathanson K, Gross J. Walsh C, Karlan B, Chenevix-Trench G, Easton DF, Antoniou AC. Pathology of breast and ovarian cancers among BRCA 1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA l /2 (CIMBA}. Cancer Epidemiol Bio markers Prev 20 l 2;21 ( l}: 134-47.

29 NYSDEC OHMS Document No. 201469232-00113 123. Obermojer N, Wong JL. Edwards RP, Odunsi K. Moysich K, Kolinski P. PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells. lmmunol Invest. 2012; 41 (6-7}: 635-57. 124. Pearce CL. Templeman C, Rossing MA, Lee A. Near AM, Webb PM, Nogle CM, Doherty JA, Cushing-Hougen KL. Wicklund KG, Chong-Claude J, Hein R, Lurie G, Wilkens LR, Corney ME, Goodmon MT. Moysich K, Kjoer SK, Hogdoll E, Jensen A, Goode EL. Fridley BL, Larson MC, Schildkraut JM, Palmieri RT, Cromer DW, Terry KL, Vitonis AF, Titus LJ, Ziogos A, Brewster W, Anton-Culver H, Gentry-Maharaj A, Ramus SJ, Anderson AR, Brueggmonn D, Fasching PA, Gayther SA, Huntsman DG, Menon U, Ness RB. Pike MC, Risch H, Wu AH, Berchuck A. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol. 2012 Apr; 13(4): 385-94. 125. Ramus SJ. Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Sinilnikova OM. Healey S, Borrowdole D, Lee A, Thomassen M. Gerdes AM. Kruse TA, Jensen UB. Skytte AB. Coligo MA. liljegren A. Lindblom A, Olsson H. Krisfoffersson U, Stenmark-Askmalm M, Melin B, Domchek SM, Nathanson KL. Rebbeck TR, Jakubowska A, Lubinski J, Jaworska K, Durda K, Zlowocka E, Gronwold J, Huzarski T, Byrski T, Cybulski C. Toloczko-Grabarek A, Osorio A. Benitez J, Duran M, Tejada Ml, Hamann U, Rookus M. van Leeuwen FE, Aalfs CM, Meijers-Heijboer HE. van Asperen CJ, van Roozendoal KE. Hoagerbrugge N, Callee JM. Kriege M, van der Luijt RB, Peock S, Frost D, Ellis SD, Platte R, Fineberg E. Evans DG, Lolloo F, Jacobs C, Eeles R, Adlord J, Davidson R. Eccles 0, Cole T, Cook J, Paterson J. Douglas F. Brewer C, Hodgson S, Morrison PJ, Walker L, Porteous ME, Kennedy MJ, Pathak H. Godwin AK, Stoppa-Lyonnet D, Coux­ Moncoutier V, de Pauw A, Gauthier-Villars M, Mozayer S, Leone M, Calender A, Losset C, Bonadona V, Hordouin A. Berthet P, Bignon YJ, Uhrhammer N, Faivre L, Loustalot C, Buys S, Daly M, Miron A. Terry MB, Chung WK, John EM, Southey M. Goldgar 0, Singer CF, Tea MK. Pfeiler G. Fink-Retter A, Hansen T, Ejlertsen B, Johonnsson OT, Offit K. Kirchhoff T, Gaudet MM, Vijai J. Robson M, Piedmonte M, Phillips KA, Van Le L, Hoffman JS, Ewart Toland A. Montagna M, Tognozza S, lmyonitov E. Issacs C. Jonovicius R, Lazaro C, Blanco I, Tornero E. Navorro M. Moysich KB. Karlan BY, Gross J, Olah E, Voszko T, Teo SH, Ganz PA, Beattie MS. Dorfling CM. van Rensburg EJ, Diez 0, Kwong A. Schmutzler RK. Wappenschmidt B, Engel C. Meindl A, Ditsch N, Arnold N. Heidemann S, Niederocher D, Preisler-Adams S, Godzicki D. Varon-Mateevo R. Deissler H, Gehrig A, Sutter C. Kast K, Fiebig B, Schafer D, Caldes T, de lo Hoya M, Nevanlinno H. Aittomoki K, Plante M. Spurdle AB, Neuhausen SL. Ding YC. Wong X, Linder N, Fredericksen Z, Pankratz VS. Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Bonanni B. Bernard L. Dolcetti R, Popi L Ottini L. Radice P, Greene MH, Mai PL. Andrulis IL, Glendon G, Ozcelik H, Pharoah PD, Gayther SA. Simard J, Easton OF, Couch FJ, Chenevix-Trench G. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA 1 and BRCA2 mutation carriers. Hum Mutat. 2012 Apr; 3314): 690-702. 126. Setiawan VW. Pike MC, Karageorgi S. Deming SL Anderson K, Bernstein L, Brinton LA. Cai H, Cerhan JR, Co.zen W, Chen C, Doherty J. Freudenheim JL, Goodman MT, Hankinson SE, Lacey JV, Jr., Liang X, Lissowsko J, Lu L. Lurie G, Mack T, Matsuno RK. Mccann S, Moysich KB, Olson SH, Rastogi R, Rebbeck TR. Risch H. Robien K. Schoirer C. Shu XO, Spurdle AB, Strom BL. Thompson PJ, Ursin G, Webb PM. Weiss NS, Wentzensen N, Xiong YB, Yang HP. Yu H. Horn-Ross PL. De Vivo I. Age at lost birth in relation to risk of endametrial cancer: pooled analysis in the epidemiology of endometriol cancer consortium. Am J Epidemiol. 2012 Aug: 17614): 269-78. 127. Tian C, Ambrosone CB, Darcy KM, Krivak TC, Armstrong DK, Bookman MA, Davis W, Zhao H. Moysich K, Gallion H, De Loia JA. Common variants in ABCB l, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian

30 NYSDEC OHMS Document No. 201469232-00113 cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Mar; 124(3): 575-81. 128. Bojesen SE, Pooley KA. Johnotty SE, Beesley J, Michoilidou K, Tyrer JP. Edwards SL, Pickett HA. Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MO, Lu Y, Karevan R, Woods N, Johnston RL, French JD, Chen X, Weischer M, Nielsen SF, Maronion MJ, Ghoussaini M, Ahmed S, Baynes C, Bolla MK, Wong Q, Dennis J, McGuffog L, Barrowdale D, Lee A. Healey S, Lush M, Tessier DC, Vincent D, Bacot F. Vergote I, Lombrechts S, Despierre E, Risch HA. Gonzolez-Neira A, Rossing MA, Pita G, Doherty JA. Alvorez N, Larson MC. Fridley Bl, Schoof N, Chong-Claude J, Cicek MS, Peto J, Kalli KR. Broeks A. Armosu SM. Schmidt MK, Broof LM, Winterhaff B. Nevonlinna H, Konecny GE, Lambrechts D. Rogmonn L Guenel P. Teamon A, Milne RL. Garcia JJ. Cox A. Shridhor V, Burwinkel B, Morme F, Hein R, Sowyer EJ, Heiman CA, Wong-Gohrke S, Andrulis IL M oysich KB, Hopper JL, Odunsi K, Lindblom A. Giles GG, Brenner H, Simard J, Lurie G, Fasching PA, Corney ME. Rodice P, Wilkens LR. Swerdlow A, Goodmon MT, Brouch H, Gorcio-Closas M, Hillemonns P, Winqvist R. Durst M. Devilee P, Runnebaum I, Jokubowsko A, Lubinski J, Mannerrnaa A, Butzow R, Bogdanovo NV, Dork T. Pelttari LM, Zheng W, Leminen A. Anton-Culver H. Bunker CH, Kristensen V, Ness RB, Muir K, Edwards R, Meindl A. Heitz F, Matsuo K, du Bois A. Wu AH, Harter P, Teo SH, Schwoab I. Shu XO. Blot W, Hosono S, Kong O, Nakanishi T, Hartman M. Yotabe Y, Homann U. Karlen BY, Songrojrang S, Kjaer SK, Gaborieou V, Jensen A. Eccles D. Hogdall E. Shen CY, Brown J, Woo YL, Shah M. Azmi MA, Luben R, Omar SZ, Czene K, Vierkont RA. Nordestgaard BG, Flyger H. Vachon C, Olson JE. Wang X, Levine DA. Rudolph A. Weber RP, Flesch-Janys D, Iversen E, Nickels S. Schildkrout JM, Silva ldos S, Cromer OW. Gibson L, Teny KL. Fletcher 0, Vitonis AF, von der Schoof CE, Poole EM, Hogervorst FB. Tworoger SS. Liu J, Bandera EV, Li J, Olson SH. Humphreys K, Orlow I. Blomqvist C. Rodriguez-Rodriguez L Aitfomaki K, Salvesen HB. Muronen TA. Wik E. Brouwers B. Krokstod C. Wouters E, Holle MK. Wildiers H, Kiemeney LA. Mulot C, Aben KK, Laurent-Puig P. Altena AM, Truong T, Mossuger LF, Benitez J, Pejovic T, Perez JI, Hootlin M, Zomora MP, Coak LS, Balasubramonion SP, Kelemen LE, Schneeweiss A, Le ND, Sohn C, Brooks-Wilson A, Tomlinson I, Kerin MJ, Miller N, Cybulski C. Henderson BE, Menkiszak J, Schumocher F, Wentzensen N. Le Marchand L. Yong HP, Mulligan AM, Glendon G, Engelholm SA, Knight JA. Hogdoll CK, Apicella C, Gore M, Tsimiklis H, Song H, Southey MC, Jager A, den Ouweland AM, Brown R, Martens JW. Flonagan JM. Kriege M, Poul J, Margolin S, Siddiqui N, Severi G. Whittemore AS, Baglietto L, McGuire V. Stegmaier C. Sieh W, Muller H, Arndt V, Labreche F, Gao YT. Goldberg MS, Yang G, Dumont M. Mcloughlin JR, Hartmann A, Ekici AB, Beckmann MW, Phelan CM. Lux MP, Permuth-Wey J, Peissel B, Sellers TA. Ficorazzi F, Barile M, Ziogas A, Ashworth A, Gentry­ Mohoraj A, Jones M, Romus SJ, Orr N, Menon U. Pearce CL, Bruning T, Pike MC, Ko YO, Lissowsko J, Figueroa J, Kupryjonczyk J, Chonock SJ, Donsonka-Mieszkowska A. Jukkolo-Vuorinen A, Rzepecka IK, Pylkos K, Bidzinski M. Kouppilo S, Hollestelle A, Seynaeve C. Tollenaor RA. Durda K, Jaworska K, Hortikoinen JM. Kosmo VM. Kotojo V. Antonenkova NN, Long J. Shrubsole M, Deming-Holverson S, Lophotananon A, Siriwonarongson P. Stewart-Brown S, Ditsch N, Lichtner P, Schmutzler RK, Ito H, Iwata H. Tajima K, Tseng CC, Strom DO. van den Berg 0, Yip CH, lkrom MK. Teh YC , Cai H, Lu W, Signorello LB. Cai Q, Noh DY, Yoo KY, Miao H, lau PT. Teo YY, McKoy J, Shapiro C, Ademuyiwo F. Fountzilos G, Hsiung CN. Yu JC. Hou MF, Heoley CS. Luccorini C, Peock S, Stoppo-Lyonnet D. Peterlongo P, Rebbeck TR, Piedmonte M. Singer CF, Friedmon E. Thomassen M. Offit K, Hansen TV, Neuhous~n SL, Szobo Cl, Blanco I, Garber J, Norod SA, Weitzel JN. Montagna M, Olah E, Godwin AK. Yonnouk.akos 0, Goldgar DE. Coldes T, lmyonitov EN, Tihomirova L, Arun BK, Campbell I, Mensenkamp AR, van Asperen CJ, van Roozendoal KE, Meijers-Heijboer H, Collee JM, Oosferwijk JC, Hooning MJ, Rookus MA, van der Luijt RB. Os TA. Evans OG, Frost D. Fineberg E, Barwell J, Walker L Kennedy

31 NYSDEC OHMS Document No. 201469232-00113 MJ. Platte R. Davidson R, Ellis SD, Cole T, Bressac-de Paillerets B, Buecher B. Damiola F, Faivre L Frenay M, Sinilnikova OM, Caron 0, Giraud S, Mazoyer S, Bonadona V, Caux­ Moncoutier V. Toloczko-Grabarek A. Gronwald J. Byrski T. Spurdle AB. Bonanni B, Zaffarani D. Giannini G. Bernard L Dolcetti R. Manoukian S. Arnold N, Engel C, Deissler H. Rhiem K. Niederacher D. Plendl H. Sutter C. Wappenschmidt B. Borg A, Melin B. Rantala J, Saller M. Nathanson KL Domchek SM, Rodriguez GC. Salani R, Kaulich DG, Tea MK, Paluch SS, Laitman Y, Skytte AB, Kruse TA, Jensen UB, Robson M. Gerdes AM, Ejlertsen B, Foretova L. Savage SA. Lester J, Soucy P, Kuchenboecker KB, Olswold C, Cunningham JM. Slager S, Pankratz VS, Dicks E. Lakhani SR. Couch FJ, Hall P, Monteiro AN, Gayther SA, Pharoah PD, Reddel RR. Goade EL Greene MH, Easton DF, Berchuck A, Antoniou AC. Chenevix-Trench G, Dunning AM. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 2013 Apr;45(4): 371-84. 129. Brosky TM, Moysich KB, Cohn DE, White E. Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort. Gynecal Oncol. 2013: 128( 1J: 113-9. 130. Erwin DO. Moysich K. Kiviniemi MT. Saad-Harfouche FG, Davis W. Clark-Hargrave N, Ciupok GL Ambrosone CB. Walker C. Community-based partnership to identify keys to biospecimen research participation. J Cancer Educ. 2013 Mar; 28( 1J: 43-51. 131. Faber MT, Kjaer SK. Dehlendorff C. Chang-Claude J, Andersen KK. Hogdall E, Webb PM. Jordan SJ. Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, Goodman MT, Ness RB. Modugno F. Edwards RP, Bunker CH, Goade EL, Fridley BL, Vierkant RA. Larson MC, Schildkraut J, Cramer DW, Terry KL, Vitonis AF, Bandera EV, Olson SH, King M. Chandron U. Kiemeney LA. Massuger LF, van Altena AM. Vermeulen SH, Brinton L, Wentzensen N, Lissawska J, Yang HP. Moysich KB. Odunsi K. Kosza K. Odunsi-Akanji O. Song H. Pharaoh P. Shah M, Whittemore AS. McGuire V, Sieh W, Sutphen R, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Pearce CL Wu AH, Pike MC. Risch HA, Jensen A. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 cose­ control studies. Cancer Causes Control. 2013 Moy: 24( 5): 989-1004. 132. Goode EL DeRycke M. Kalli KR, Oberg AL. Cunningham JM, Maurer MJ, Fridley BL Armasu SM, Serie DJ. Romar P. Goergen K, Vierkant RA, Rider DN. Sicotte H, Wang C, Winterhoff B, Phelan CM, Schildkrout JM, Weber RP, Iversen E, Berchuck A, Sutphen R, Birrer MJ, Hampras S, Preus L Gayther SA. Ramus SJ, Wentzensen N. Yang HP, Garcia­ Closas M. Sang H, Tyrer J, Pharoah PP. Konecny G. Sellers TA. Ness RB. Sucheston LE. Odunsi K, Hartmann LC, Moysich KB. Knutson KL. Inherited variants in regulatory T cell genes and outcome of ovarian cancer. PLoS One. 2013: 8(1 ): e53903. 133. Kelemen LE, Bandera EV, Terry KL, Rossing MA, Brinton LA. Doherty JA, Ness RB, Kjaer SK, Chang-Claude J. Kabel M, Lurie G, Thompson PJ. Carney ME, Moysich K, Edwards R, Bunker C. Jensen A, Hagdoll E, Cramer DW. Vitonis AF. Olson SH, King M, Chondran U, Ussowsko J. Garcia-Closos M. Yang H, Webb PM, Schildkraut JM, Goodman MT, Risch HA. Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 coses and l 0,358 controls from the Ovarian Cancer Association Consortium. BMC Cancer. 2013 Jan 22; 13: 28. 134. Kiviniemi MT, Saad-Harfouche FG, Ciupak GL, Davis W, Moysich K, Hargrave NC, Ambrosone CB. Walker C. Erwin DO. Pilot intervention outcomes of an educational program for biospecimen research participation. J Cancer Educ. 2013 Mar: 28( 1J:52-9. 135. Olsen CM, Nagle CM, Whiteman DC. Ness R, Pearce CL, Pike MC. Rossing MA, Terry KL, Wu AH, Risch HA. Yu H, Doherty JA, Chong-Claude J, Hein R, Nickels S, Wang-Gohrke S. Goodman MT. Carney ME, Matsuno RK, Lurie G. Moysich K. Kjaer SK. Jensen A, Hogdall E. Goode EL, Fridley BL Vierkant RA, Larson MC, Schildkraut J, Hoyo C, Moorman P, Weber RP. Cromer DW. Vitonis AF, Bandera EV. Olson SH, Rodriguez­ Rodriguez L, King M. Brinton LA. Yang H. Garcia-Clasas M, Lissowsko J, Anton-Culver H. 32 NYSDEC OHMS Document No. 201469232-00113 Ziogas A, Gayther SA. Ramus SJ. Menon U. Gentry-Maharaj A. Webb PM. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer. 2013 MAr 22; 20(2): 251-62. 136. Pearce CL Rossing MA. Lee AW, Ness RB. Webb PM, Chenevix-Trench G. Jordon SJ, Strom DA. Chang-Claude J, Hein R, Nickels S, Lurie G, Thompson PJ, Carney ME. Goodmon MT, M oysich KB, Hogdall EV. Jensen A, Goade EL Fridley BL Cunningham JM, Vierkant RA, Weber RP. Ziogas A. Anton-Culver H, Goyther SA. Gentry-Maharaj A, Menon U, Ramus SJ, Brinton LA. Wentzensen N, Ussowska J, Garcia-Closas M, Massuger L Kiemeney LA. van Altena AM, Aben KK, Berchuck A. Doherty JA. Iversen E, McGuire V, Moorman PG. Pharoah PD, Pike MC, Risch HA, Sieh W, Stram DO, Terry KL Whittemore AS. Wu A, Schildkrout JM, Kjaer SK. Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2013 May; 22{5): 880-90. 137. Permuth-Wey J, Lawrenson K. Shen HC. Velkava A. Tyrer JP, Chen Z, Un HY, Ann Chen Y, Tsai YY, Qu X. Ramus SJ, Karevan R, Lee J, Lee N. Larson MC, Aben KK, Anton-Culver H, Antonenkova N. Antoniou AC, Armasu SM. Bacot F. Baglietto L, Bandera EV, Barnholtz-Sloan J, Beckmann MW. Birrer MJ, Bloom G, Bogdanova N. Brinton LA, Brooks-Wilson A, Brown R. Butzow R, Cai Q, Campbell I, Chong-Claude J, Chonock S, Chenevix-Trench G, Cheng JQ, Cicek MS, Coetzee GA, Cook LS. Couch FJ, Cramer DW, Cunningham JM. Dansonka-Mieszkowsko A, Despierre E. Doherty JA. Dork T. du Bois A, Durst M, Easton DF, Eccles D, Edwards R, Ekici AB, Fasching PA, Fenstermacher DA, Flanagan JM, Gorcia-Closos M, Gentry-Maharaj A, Giles GG, Glasspool RM. Gonzolez-Bosquet J. Goodmon MT, Gore M. Gorski B. Gronwald J, Hall P, Holle MK, Harter P, Heitz F, Hillemanns P. Hoatlin M, Hogdoll CK. Hogdall E. Hosono S, Jokubowska A. Jensen A. Jim H, Kalli KR, Karlan BY, Kaye SB. Kelemen LE, Kiemeney LA. Kikkowo F, Konecny GE Krakstad C. Kruger Kjaer S, Kupryjanczyk J, Lambrechts D. Lombrechts S. Lancaster JM. Le ND, Leminen A. Levine DA. Liang D, Kiong Lim B. Lin J, Lissowska J, Lu KH, Lubinski J, Lurie G, Mossuger LF, Matsuo K. McGuire V, Mcloughlin JR, Menon U. Modugno F, Moysich KB, Nakanishi T. Narod SA, Nedergoard L Ness RB, Nevanlinno H, Nickels S, Noushmehr H, Odunsi K. Olson SH, Orlow I, Paul J, Pearce CL, Pejovic T, Pelttori LM. Pike MC. Poole EM. Raska P. Renner SP. Risch HA. Rodriguez-Rodriguez L Anne Rossing M, Rudolph A. Runnebaum IB, Rzepecko IK. Salvesen HB, Schwoab I, Severi G, Shridhar V, Shu XO. Shvetsov YB. Sieh w. Song H, Southey MC, Spiewonkiewicz B, Stram D. Sutphen R. Teo SH, Terry KL. Tessier DC, Thompson PJ, Tworoger SS, van Altena AM, Vergote I. Vierkont RA, Vincent D. Vifonis AF, Wang­ Gohrke S, Palmieri Weber R, Wentzensen N, Whittemore AS, Wik E. Wilkens LR, Winterhoff B, Ling Woo Y. Wu AH, Xiang YB, Yang HP, Zheng W, Ziogas A. Zulkifli F, Phelan CM. Iversen E, Schildkraut JM. Berchuck A, Fridley Bl, Goode EL, Pharaoh PD, Monteiro AN. Sellers TA. Gayther SA. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Not Commun. 2013; 4: 1627. 138. Pharoah PD, Tsai YY. Ramus SJ, Phelan CM, Goode EL, Lawrenson K. Buckley M. Fridley BL. Tyrer JP, Shen H. Weber R. Korevan R, Larson MC. Song H, Tessier DC, Bacot F, Vincent D, Cunningham JM, Dennis J. Dicks E. Aben KK, Anton-Culver H, Antonenkovo N. Armasu SM, Baglie tto L, Bandera EV, Beckmann MW. Birrer MJ. Bloom G, Bogdanova N. Brenton JD. Brinton LA, Brooks-Wilson A, Brown R. Butzow R, Campbell I, Carney ME, Carvalho RS. Chong-Claude J, Chen YA. Chen Z. Chow WH, Cicek MS, Coetzee G, Cook LS, Cramer DW, Cybulski C. Donsanka-Mieszkowska A, Despierre E, Doherty JA. Dork T, du Bois A, Durst M, Eccles D, Edwards R. Ekici AB. Fasching PA, Fenstermacher D, Flonagon J, Goo YT, Garcia-Closes M, Gentry-Maharaj A, Giles G, Gjyshi A, Gore M, Gronwald J, Guo Q, Holle MK, Harter P, Hein A. Heitz F, Hillemonns P. Hoatlin M, Hogdall E. Hogdall CK. Hosono $, Jakubowska A. Jensen A. Kalli KR, Korlan BY, Kelemen LE, Kiemeney LA, Kjaer SK, Konecny GE. Krokstod C, Kupryjanczyk J, 33 NYSDEC OHMS Document No. 201469232-00113 Lambrechts D. Lambrechts S, Le ND, Lee N. Lee J. Leminen A. Lim BK, Lissowska J, Lubinski J, Lundvall L. Lurie G, Massuger LF. Matsuo K, McGuire V, Mclaughlin JR, Menon U, Modugno F. Moysich KB, Nakanishi T, Narod SA. Ness RB, Nevanlinna H. Nickels S, Noushmehr H, Odunsi K, Olson S, Orlow I. Paul J, Pejovic T, Pelttari LM, Permuth-Wey J, Pike MC, Poole EM. Qu X, Risch HA. Rodriguez-Rodriguez L. Rossing MA. Rudolph A. Runnebaum I. Rzepecko IK, Salvesen HB, Schwaab I, Severi G, Shridhar V. Shu XO, Sieh W, Southey MC, Spellman P. Tajima K. Teo SH. Terry KL Thompson PJ, Timorek A. Tworoger SS, van Altena AM, van den Berg D. Vergote I, Vierkont RA, Vitonis AF, Wang-Gehrke S. Wentzensen N, Whittemore AS, Wik E, Winterhoff B. Woo YL. Wu AH. Yang HP. Zheng W, Ziogas A, Zulkifli F, Goodmon MT, Hall P. Easton DF, Pearce CL Berchuck A, Chenevix-Trench G. Iversen E. Monteiro AN, Goyther SA. Schildkraut JM, Sellers TA. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet. 2013 Apr; 45(4):362-70. 139. Shen H. Fridley BL Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Strom D. Larson MC. Kobel M, Ziogas A. Zheng W. Yang HP, Wu AH. Wozniak EL. Ling Woo Y. Winterhoff B. Wik E. Whittemore AS, Wentzensen N, Palmieri Weber R, Vitonis AF, Vincent D. Vierkant RA. Vergote I, Van Den Berg D, Van Altena AM. Tworoger SS, Thompson PJ. Tessier DC, Terry KL. Teo SH, Templeman C, Strom DO, Southey MC. Sieh W, Siddiqui N. Shvetsov YB, Shu XO, Shridhar V, Wang-Gehrke S, Severi G. Schwaob I, Salvesen HB, Rzepecka IK, Runnebaum IB, Anne Rossing M, Rodriguez-Rodriguez L Risch HA. Renner SP, Poole EM. Pike MC, Phelan CM, Pelttari LM, Pejovic T, Paul J, Orlow I, Zawiah Omar S. Olson SH. Odunsi K, Nickels s. Nevanlinna H, Ness RB. Narod SA. Nakanishi T. Moysich KB. Monteiro AN, Moes-Sosnowsko J. Modugno F. Menon U, Mclaughlin JR, McGuire V, Matsuo K, Mot Adenan NA. Mossuger LF. Lurie G, Lundvall L Lubinski J, Lissowska J, Levine DA. Leminen A. Lee AW, Le ND, Lambrechts S, Lombrechts D. Kupryjonczyk J, Krakstad C. Konecny GE, Kruger Kjaer S, Kiemeney LA. Kelemen LE. Keeney GL, Karlan BY. Karevon R. Kalli KR, Kajiyamo H, Ji BT, Jensen A. Jakubowska A. Iversen E, Hosono S, Hogdall CK, Hogdall E, Hoatlin M. Hillemanns P. Heitz F. Hein R. Harter P, Halle MK. Hall P. Gronwald J. Gore M. Goodman MT. Giles GG, Gentry-Maharaj A. Garcia-Closas M, Flanagan JM. Fasching PA. Ekici AB. Edwards R, Eccles D. Easton DF. Durst M. du Bois A, Dork T. Doherty JA. Despierre E, Dansanka­ Mieszkowska A, Cybulski C. Cramer OW, Cook LS. Chen X, Charbonneau B, Chang­ Claude J. Campbell I, Butzow R, Bunker CH. Brueggmann D, Brown R. Brooks-Wilson A. Brinton LA. Bogdanova N. Block MS. Benjamin E, Beesley J. Beckmann MW. Bandera EV. Baglietto L, Bacot F. Armasu SM, Antonenkova N, Anton-Culver H, Aben KK, Liang D, Wu X. Lu K, Hildebrandt MA. Schildkraut JM, Sellers TA. Huntsman D. Berchuck A. Chenevix-Trench G. Gayther SA, Phoroah PD, Laird PW. Goode EL Leigh Pearce C. Epigenetic analysis leads to identification of HNFl Bas a subtype-specific susceptibility gene for ovarian cancer. Nat Commun. 2013; 4: 1628. 140. Sieh W, Salvador S. McGuire V, Weber RP, Terry KL, Rossing MA, Risch H, Wu AH, Webb PM. Moysich K. Doherty JA. Felberg A. Miller D, Jordan SJ, Goodman MT, Lurie G. Chang-Claude J, Rudolph A, Kjoer SK, Jensen A, Hogdall E, Bandera EV, Olson SH, King MG. Rodriguez-Rodriguez L Kiemeney LA. Marees T. Massuger LF. van Altena AM. Ness RB. Cromer OW. Pike MC, Pearce CL Berchuck A. Schildkraut JM, Whittemore AS. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. Int J Epidemiol. 2013 Apr; 42(2): 579-89. 141. Setiawan VW. Yong HP, Pike MC. Mcconn SE, Yu H, Xiong YB. Wolk A, Wentzensen N. Weiss NS. Webb PM, van den Brandt PA, van de Vijver K. Thompson PJ; Australian Notional Endometrial Cancer Study Group, Strom BL Spurdle AB, Soslow RA. Shu XO, Schoirer C. Socerdote C, Rohan TE. Robien K. Risch HA. Ricceri F. Rebbeck TR, Rastogi R, Prescott J. Polidoro S, Park Y. Olson SH. Moysich KB, Miller AB. McCullough ML Matsuno RK. Magliocco AM. Lurie G, Lu L Lissowska J, Liang X, Locey JV Jr, Kolonel LN. 34 NYSDEC OHMS Document No. 201469232-00113 Henderson BE, Hankinson SE, Hakansson N, Goodman MT, Gaudet MM, Garc.ia-Closas M, Friedenreich CM, Freudenheim JL, Doherty J, De Vivo L Courneya KS. Caok LS, Chen C, Cerhan JR, Cai H, Brinton LA, Bernstein L, Anderson KE, Anton-Culver H, Schouten LJ, Horn-Ross PL. Type I and II Endometrial Cancers: Have They Different Risk Factors? J Clin Oncol. 2013 Jul l 0;31 {20):2607-18. 142. Terry KL Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson P, Carney ME. Weber RP. Akush.evich L, Lo-Ciganic WH, Cushing-Haugen KL, Sieh W, Moysich KB, Doherty JA, Nagle CM, Berchuck A, Pearce CL Pike M. Ness RB, Webb P, Rossing MA, Schildkraut J, Risch HA, Goodman MT. Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls. Cancer Prev Res (Philo). 2013 Aug:6(8):811 -21. 143. Sieh W, Kobel M, Longacre TA, Bowtell DD, Defazio A, Goodman MT. He21gdall E, Deen S. Wentzensen N. Movsich KB, Brenton JD, Clarke BA, Menon U, Gilks CB, Kim A, Madore J, Fereday S, George J, Galletta L Lurie G, Wilkens LR, Carney ME, Thompson PJ, Matsuno RK, Kjcer SK, Jensen A. He21gdall c. Kalli KR, Fridley BL, Keeney GL, Vierkant RA, Cunningham JM, Brinton LA, Yang HP, Sherman ME, Garda-Closas M. Lissowska J, Odunsi K, Marrison C, Lele S, Bshara W, Sucheston L, Jimenez-Linan M, Driver K, Alsop J, Mack M, McGuire V. Rothstein JH, Rosen BP, Bernardini MQ, Mackay H, Oza A, Wozniak EL, Benjamin E, Gentry-Maharaj A Gayther SA. Tinker AV, Prentice LM, Chow C. Anglesio MS. Johnatty SE. Chenevix-Trench G, Whittemore AS, Pharoah PD, Goade EL Huntsman DG, Ramus SJ. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol. 2013 Aug;l 4(9) :853-62. 144. Koebel M, Kalloger S. Lee S, Duggan MA, Kelemen LE, Prentice L, Kalli KR, F;idley BL Visscher DW, Keeney GA. Vierkant RA. Cunningham JM, Chow C, Ness RB, Moysich KB, Edwards RP, Modugno F. Bunker CH, Wozniak EL Benjamin E. Gayther SA, Gentry-Maharaj A, Menon U, Gilks B. Huntsman DG, Ramus SJ, Goode EL. Biomarker­ based ovarian carcinoma typing: a histological investigation in the Ovarian Tumor Tissue Analysis consortium. Cancer Epidemiol Biomorkers Prev. 2013 Oct; 22( 10): 1677- 86. 145. Andreotti G, Birmann B. De Roos AJ. Spinelli J, Cozen W, Camp NJ, Moysich K, Chiu B. Steplawski E. Krzyston J, Boffetta P, Benhaim-Luzon V, Brennan P, de Sanjose S, Costas L Costantini AS. Miligi L Cocco P, Becker N, Foretov6 L, Maynadie M, Nieters A, Staines A, Tricot G, Milliken K, Weisenburger D. Zheng T. Baris D. Purdue MP. A Pooled Analysis of Alcohol Consumption and Risk of Multiple Myeloma in the International Multiple Myeloma Consortium. Cancer Epidemiol Biomorkers Prev. 2013 Sep; 22(9): 1620-7. 146. Tian CQ, Darcy KM, Krivak TC, Deloia JA, Armstrong D, Davis W, Zhao H, Movsich K, Ambrosone CB. Assessment of the Prognostic Value of Two Common Variants of BRCA 1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group Study. Front Oncol. 2013 Aug 12; 3:206. 147. Earp MA, Kelemen LE, Magliocco AM, Swenerton KD. Chenevix-Trench G; Australian Cancer Study; Australian Ovarian Cancer Study Group, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D. Despierre E. Vergote I, Lambrechts S, Doherty JA. Rossing MA, Chang-Claude J, Rudolph A, Friel G, Moysich KB. Odunsi K, Sucheston-Campbell L Lurie G, Goodman MT. Carney ME, Thompson PJ, Runnebaum IB, Durst M, Hillemanns P, Dork T, Antanenkova N, Bogdanova N, Leminen A, Nevonlinna H, Pelttari LM, Butzow R, Bunker CH, Modugno F, Edwards RP, Ness RB, du Bois A, Heitz F, Schwaab I, Harter P, Karlan BY, Walsh C. Lester J, Jensen A, Kjcer SK, H0gdall CK. H0gdall E. Lundva.11 L, Sellers TA, Fridley BL, Goode EL, Cunningham JM, Vierkant RA, Giles GG, Boglietta L Severi G, Southey MC, Liang D, Wu X, Lu K, Hildebrandt MA, Levine DA. Bisogno M, Schildkraut JM, Iversen ES. Weber RP,

35 NYSDEC OHMS Document No. 201469232-00113 Berchuck A, Cramer DW. Terry KL, Poole EM, Tworoger SS, Bandera EV, Chandran U, Orlow I. Olson SH. Wik E, Salvesen HB, Bjorge L, Halle MK, van Altena AM, Aben KK. Kiemeney LA, Massuger LF, Pejovic T, Bean YT, Cybulski C, Gronwald J, Lubinski J, Wentze.nsen N, Brinton LA, Lissowska J, Garcia-Clasas M, Dicks E. Dennis J, Easton DF. Song H, Tyrer JP, Pharoah PD, Eccles D, Campbell IG, Whittemore AS, McGuire V, Sieh W, Rothstein JH, Flanagan JM, Paul J, Brown R, Phelan CM, Risch HA, Mclaughlin JR, Narod SA, Ziogas A, Anton-Culver H, Gentry-Maharaj A. Menon U, Gayther SA, Ramus SJ. Wu AH, Pearce CL, Pike MC, Dansanka-Mieszkowska A, Rzepecka IK, Szafran LM, Kupryjanczyk J, Coak LS, Le ND, Brooks-Wilson A; On behalf of the Ovarian Cancer Association Consortium. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet. 2014 May; 133(5) :481-97. 148. Hampras SS. Movsich KB. Marimuthu SP. Ravi V, Jayaprakash V. Socioeconomic factors and the risk for sarcoma. Eur J Cancer Prev. 2013 Dec 18. 149. Akers SN, Moysich K, Zhang W, Collamat Lai G. Miller A, Lele S, Odunsi K, Karpf AR. LINEl and Alu repetitive element DNA methylation in tumors and white blood cells from epithelial ovarian cancer patients. Gynecol Oneal. 2013 Dec 25. [Epub ahead of print]. 150. Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA. Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeney LA, Baglietto L, Giles GG, Severi G, Trabert B, Wentzensen N, Chenevix-Trench G; for AOCS/ACS group, Whittemore AS, Sieh W, Chang-Claude J, Bandera EV. Orlow I. Terry K. Goodman MT. Thompson PJ, Cook LS. Rossing MA. Ness RB. Narod SA, Kupryjanczyk J, Lu K. Butzow R. Dork T, Pejovic T, Campbell I. Le ND. Bunker CH. Bogdanova N, Runnebaum IB. Eccles D, Paul J, Wu AH, Gayther SA, Hogdall E. Heitz F. Kaye SB, Karlan BY, Anton-Culver H, Gronwald J, Hogdall CK. Lambrechts D. Fasching PA, Menon U, Schildkraut J, Pearce CL, Levine DA. Kjaer SK, Cramer D, Flanagan JM, Phelan CM, Brown R, Massuger LF, Sang H. Doherty JA, Krakstad C, Liang D, Odunsi K, Berchuck A, Jensen A. Lubinski J, Nevanlinna H. Bean YT, Lurie G, Ziogas A, Walsh C. Despierre E. Brinton L, Hein A. Rudolph A, Dansonka-Mieszkowska A, Olson SH, Harter P, Tyrer J, Vitonis AF, Brooks-Wilson A. Aben KK, Pike MC. Ramus SJ. Wik E, Cybulski C. Lin J. Sucheston L, Edwards R. McGuire V, Lester J, du Bois A, L•Jndvall L. Wang-Gohrke S. Szafran LM. Lambrechts S, Yang H, Beckmann MW, Pelttari LM. Van Altena AM, van den Berg D, Halle MK, Gentry-Maharaj A, Schwaab I. Chandron U. Menkiszak J, Ekici AB. Wilkens LR. Leminen A. Modugno F. Friel G, Rothstein JH, Vergote I, Garcio-Closas M. Hildebrandt MA, Sobiczewski P, Kelemen LE. Pharaoh PD, Moysich K. Knutson KL Cunningham JM, Fridley BL Goode EL. Risk of Ovarian Cancer and the NF- B Pathway: Genetic Association with IL l A and TNFSFlO. Cancer Res. 2014 Feb l; 74(3):852-61. 151. Kelemen LE. Terry KL. Goodman MT, Webb PM, Bandera EV, McGuire V, Rossing MA, Wang Q, Dicks E. Tyrer JP, Song H, Kupryjanczyk J, Dansonka-Mieszkowska A. Plisiecko-Halasa J. Timorek A, Menon U, Gentry-Maharaj A, Gayther SA, Ramus SJ, Narod SA, Risch HA, Mclaughlin JR, Siddiqui N, Glasspool R, Paul J. Carty K. Gronwald J, Lubi ,ski J, Jakubowsko A. Cybulski C, Kiemeney LA, Massuger LF. van Altena AM, Aben KK. Olson SH, Orlow I. Cramer ow. Levine DA. Bisagna M. Giles GG. Southey MC, Bruinsmo F, Kjaer SK, H0gdall E, Jensen A. H0gdall CK, Lundvall L, Engelholm SA, Heitz F, du Bois A, Harter P, Schwaab I, Butzow R, Nevanlinna H, Pelttari LM. Leminen A, Thompson PJ, Lurie G. Wilkens LR. Lambrechts D. Van Nieuwenhuysen E, Lambrechts S. Vergote I, Beesley J; AOCS Study Group/ ACS Investigators, Fasching PA, Beckmann MW, Hein A, Ekici AB. Doherty JA, Wu AH, Pearce CL. Pike MC, Stram D, Chong-Claude J, Rudolph A, Dork T, Durst M, Hillemanns P. Runnebaum 18, Bagdanava N, Antonenkova N, Odunsi K, Edwards RP, 36 NYSDEC OHMS Document No. 201469232-00113 Kelley JL Modugno F, Ness RB, Karlan BY, Walsh C, Lester J, Orsulic S, Fridley BL, Vierkant RA, Cunningham JM, Wu X. Lu K, Liang D, Hildebrandt MA. Weber RP. Iversen ES, Tworoger SS, Poole EM, Salvesen HB, Krakstad C, Bjorge L, Tangen IL Pejovic T, Bean Y. Kellar M, Wentzensen N, Brinton LA. Lissowska J, Garcia-Closas M, Campbell IG, Eccles D, Whittemore AS, Sieh W, Rothstein JH, Anton-Culver H. Ziogas A, Phelan CM, Moysich KB, Goode EL, Schildkraut JM, Berchuck A, Pharoah PD. Sellers TA, Brooks-Wilson A, Cook LS, Le ND. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mal Nutr Food Res. 2014 Jul 28. 152. Conway DI, Brenner DR. McMahon AD, Macpherson LM, Agudo A, Ahrens W. Basetti C, Brenner H. Castellsague X, Chen C. Curada MP. Curioni OA. Maso LD, Daudt AW. de Gois Filho JF. D'Souza G, Edefonti V, Fabianova E. Fernandez L, Franceschi S. Gillison M, Hayes RB. Healy CM. Herrero R, Holcatova L Jayaprakash V, Kelsey K, Kjaerheim K. Koifman S, Vecchia CL, Lagiou P, Lazarus P, Levi f, Lissowska J, Luce D, Macfarlane TV, Mates D, Matas E, McC!ean M. Menezes AM, Menvielle G, Merletti F, Morgenstern H, Moysich K, Muller H, Muscat J, Olshan AF. Purdue MP, Ramroth H. Richiardi L Rudnai P. Schantz S, Schwartz SM, Shangina 0, Simonato L, Smith E. Stucker I, Sturgis EM. Szeszenia-Dabrowska N. Talamini R, Thomson P, Vaughan TL, Wei Q, Winn DM, Wunsch-Filho V, Yu GP, Zhang ZF, Zheng T, Znaar A, Boffetta P, Chuang SC, Amy Lee YC, Hashibe M. Brennan P. Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries. Int J Cancer. 2014 Jul 4. [Epub ahead of print] 153. Galeone C, Edefonti V, Parpinel M, Leoncini E, Matsuo K, Talamini R. Olshan AF, Zevallos JP, Winn DM, Jayaprakash V, Moysich K. Zhang ZF. Morgenstern H. Levi F. Bosetti C, Kelsey K, McClean M, Schantz S, Yu GP, Boffetta P, Lee YC. Hashibe M. La Vecchia C, Boccia S. Folate intake and the risk of oral cavity and pharyngeal cancer: A pooled analysis within the International Head and Neck Cancer Epidemiology Consortium. Int J Cancer. 2014 Jun 26. [Epub ahead of print] 154. Charbonneau B, Moysich KB, Kalli KR, Oberg AL Vierkant RA. Fogarty ZC, Block MS, Maurer MJ, Goergen KM, Fridley BL Cunningham JM, Rider DN, Preston C. Hartmann LC, Lawrenson K. Wang C, Tyrer J, Song H, deFazio A. Jahnatty SE, Doherty JA, Phelan CM, Sellers TA. Ramirez SM, Vitonis AF. Terry KL Van Den Berg D. Pike MC. Wu AH, Berchuck A, Gentry-Maharaj A, Ramus SJ. Diergaarde B. Shen H, Jensen A, Menkiszak J. Cybulski C. Lubi ski J, Ziogas A. Rothstein JH, McGuire V, Sieh W, Lester J, Walsh C, Vergote I, Lambrechts S. Despierre E, Garcia-Closas M. Yang H, Brinton LA, Spiewankiewicz B, Rzepecka IK, Dansonka-Mieszkowska A, Seibold P, Rudolph A. Paddock LE, Orlow L Lundvall L, Olson SH, Hogdall CK, Schwaab I, du Bois A, Harter P, Flanagan JM, Brown R, Paul J, Ekici AB, Beckmann MW, Hein A. Eccles D. Lurie G, Hays LE. Bean YT. Pejavic T. Goodman MT, Campbell I, Fasching PA, Konecny G. Kaye SB. Heitz F. Hogdall E. Bandera EV, Chang-Claude J, Kupryjanczyk J. Wentzensen N, Lambrechts D. Karlan BY, Whittemore AS, Culver HA. Gronwald J, Levine DA. Kjaer SK, Menon U. Schildkraut JM, Pearce CL Cramer DW, Rossing MA, Chenevix-Trench G; AOCS group; ACS, Pharoah PD, Gayther SA, Ness RB, Odunsi K, Sucheston LE, Knutson KL, Goode EL. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer lmmunol Res. 2014 Apr 2(4):332-40.

BOOK CHAPTERS

37 NYSDEC OHMS Document No. 201469232-00113 1. Moysich KB. Environmental Exposure to Potychlorinated Biphenyls and Breast Cancer Risk. In: PCBs: Recent Advances in Environmental Toxicology and Health Effects. LW Robertson and LG Hansen {Eds). University Press of Kentucky. Lexington, KY, pp.119- 126. 2. Longnecker MP, Korrick SA. Moysich KB. Human health effects of polychlorinoted biphenyls. In: Dioxins and Health. 2nd Ed (Schecter A Gasiewicz TA. eds.}. Hoboken, NJ: Wiley-lnterscience, 2003:679-728. 3. Ambrosone CB. Moysich KB, Furberg H. Breast Cancer. In: Cancer Risks Assessment. (Shields PG. ed.). Boca Roton. FL: Taylor & Francis, 2005:475-502.

LAY PUBLICATIONS

1. Moysich KB. Research Commentary: Thoughts on Recent Findings Regarding Organochlorines and Breast Cancer Risk. The Ribbon 2001; 6 (3}: 5-6. 2. Moysich KB. Unbalanced Reports. Media Bias: Industrial By-Products and Breast Cancer Risk. MAMM Magazine 2002; 5:34.

38 NYSDEC OHMS Document No. 201469232-00113

EXHIBIT 13 NYSDEC OHMS Document No. 201469232-00113 SEARCH:; go " Crop and Soil Sciences r. Cornell

School of Integrative Plant Science Crop and Soil Sciences Section

P:;oplt:

People Home I People I Murray McBride Departments

• Crop and Soil Sciences Faculty and Academic Murray McBride Staff Concentrations Adjunct and Emerltus Professor Faculty 910 Bradfield Hall • Organic Residuals • Heavy Metals Associates and Fellows (607) 255-1728 • Lead {Pb) • Urban Gar

Outreach and Extension Focus As part of my outreach activities, I am involved in working with extension staff at Cornell in developing guidelines and publications on the management of toxic metals that may he found al elevated concentrations in some farm and garden soils. Practical methods of remediating contaminated soils are being investigated, and recommendations are being conveyed to growers based on these findings.NYSDEC Impro OHMSved methods Document of testing No. contaminated 201469232-00113 soils for toxic metals such as lead, zinc, cadmium, arsenic and copper, and interpreting these tests, is also a focus of my outreach effort. The goal is to provide fanners and gardeners \\ith science-based information to minimize their exposure to toxic metals and other contaminants in soils as weJI as impro-.·e crop quality.

Teaching Focus My teaching attempts to ex11lain to students the chemical processes that go on the complex emironment of soils b}' using simple ph~·sical chemical principles. l teach an undergraduate course in Em~ronmenta l Chemistry, which CO\'ers important environmental topics in soils, the atmosphere, and the hydrosphere. This course uses case studies of poll ution in the biosphere and considers the potential effects on soil, plant, animal and human health. Because new environmental issues nre emerging every year as more is learned, lectures evolve in response to this dynamic situation. I also teach an advanced soil chemistry course, intended primarily for graduate students with a strong background in ph}'Sical chemistry.

This course CO\'ers the basic chemist I)' of clay mineralogy, soil organic matter, soil acidity, cation exchange, chemisorption of metal cations and oxyanions, redox processes and soil salinity.

Selected Publications J onrnal Publications

• Xiao, X., Sun, S. P., McBride, M. D., & Lemley, A. T. (2012). Degradation ofciprofloxacin by cryptomelane-type manganese { 111/ IV) oxides. Enviromenlal Science anu Pollution Research. 20:10-21. • Udovic, M., & McBride, M. D. {2012). lnOuence of compost addition on lead and arsenic bioavailability in reclaimed orchard soil assessed using Porcellio se<.1ber bioaccumul otion test. .Journal of J-l ai.ardous Materi als. 205-206: 144-149. • McBride, M. B., Simon, T., Tam, G., & Wharton, S. {2012). Lead and arsenic uptake by leafy vegetables grown on contaminated soils: Effects of mineral and organic amendments. Water, Air, and Soil Pollution. 224:1378. • Wharton, S. E., Shayler, H. A., Spllethoff, H. M., Marquez-Bravo. L. G., Rihaudo, L, & McBride, M. B. {2012). A comparison of screening tests for soil Pb. Soil Science Joumal. 177:650-654. • McBride, M. B. (2011). A comparison of reliability of soil cadmium determination by standard spectrometric methods. .Journal of Emironmental Quality. 40: i863-1869. • McBride, M. B., X C Chen ,, G C Chen,. LG Chen., Y X Chen ., Lehmann, J., & Hay, A.G. (2011). Adsorption of copper and zinc hy biochars produced from pyrolrsis of hardwood anu corn straw in aqueous solution .. Bioresourcc Technology. 102:8877-8884. • McBride, M. B., BJ Ki m ,, Y S Kim ., B M Kim ., & Hay, A.G. (2011). Effect of soil metal contamination on glyphosate mineralization: role of zinc in the mineraliuition rates of two copper-spiked mineral NYSDEC OHMS Document No. 201469232-00113 soils.. Emironmental Toidcology and Chemistry. 30:596-601. • McBride, M. B., Pitiranggon, M., & Kim, ll. (2009). A Comparison of Tests for Extractable Copper and Zinc in Metal-Spiked and Field· Contaminated Soil. Soil Science ,Journal. 174:439-4-14. • McBride, M. B., Richards, B. K, Steenhuis, T. S., Russo, J. J .. & Suave, S. (1997). Mobility and solubility of toxic metals and nutrients in soil fifteen years after sludge application. Soil Science. 162:487-500.

Olhcr

• Harrison, E. Z., & McBride, M. B. (2009). Case for Caution Re'\isited: Health and Emironmental lmpacts of Application of Sewage Sludges to Agricultural Land. p. 1-28 Cornell Waste Management Institute, Ithaca, NY NYSDEC OHMS Document No. 201469232-00113

Co-author Count Hale, B 2 Li, Ninguy 1 Martinez, Carr 17 Dousset, S 1 Shayler, Hann• 2 Sauvv'©, S. 3 Li, Zhian 1 Hay, Anthony 5 Evans, L J 1 Kim, Boeong 1 Xiao, X 1 Shi, Dezhi 1 Qureshi, S 4 Kim, Bojeong 3 McDowell, W 1 Richards, Bria1 21 Klitzke, S 1 Ketterings, Qu 4 Lopp, D. M. 1 Fang, Jie 1 Bouldin, D. R. 1 Harrison, E 1 Cherney, Debt 1 Hendershot, VI 1 Wang, Yunlon~ 1 Baveye, P 11 Baker, L 1 Ribaudo, Lisa 1 Lehmann, Joh; 1 Hay, A 1 Ribaudo, L. N. 1 Mitchell, R. G. 1 Brock, E1izabe· 1 Martinez, C E 5 Brock, EH 2 Chen, G 1 Kim, B 3 Aguirre-Gome. 2 Spliethoff, Her 2 Lambert, Vero 1 Kandianis, M 1 2 Nibarger, E. A. 1 Jacobson, A. 2 Tam, Geoffrey 1 Zhuang, Ping 1 Udovic, Metka 1 Akhtar, MS 1 Norvell, Wendi 2 NYSDEC OHMS Document No. 201469232-00113

Yoon, SJ 1 Suave, S 1 Wharton, Sara 1 McDowell, M 1 Stone, E. B. 1 Rao Mathur, R• 1 Shen, Chaofer 1 Harrison, Eller 8 Tsai, CC 1 Sun, SP 1 Li, Z.A. 1 Zho, B. 1 Russell-Anelli, 1 Duxbury, John 2 Spiers, G 2 Dickson, P 1 Li, N.Y. 1 Schulte, BM 1 Yoon, S. 1 Russo, J J 1 Barrett, KimbE 7 Stehouwer, R 2 Zhuang, P. 1 Marquez-Brav< 2 Simon, Tobi 1 Xia, Hanping 1 Wharton, Sara 1 Lemley, Ann T. 1 Cherney, Jerry 2 Pitiranggon, M 1 Chen, X 1 Chen, Y. 1 Peverly, J H 3 Topp, E. 1 camobreco, v 1 Bleam, W F 2 Liu, Yuxue 2 Jacobson, A. F 10 Heilig, A 1 Chen, L 1 Newton, J 2 Barker, A 2 Kim, BJ 1 Brock, E 1 Tang, Xianjin 1 Hua, Li 3 Chen, Yingxu 4 Ferenz, Gretct 1 Steenhuis, Tar 23 NYSDEC OHMS Document No. 201469232-00113

Krogmann, u 2 Martv'=Fnez, C 1 Evans, L. 1 Spagnuolo, M 4 Wu, Weixiang 4